Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 17, 2026.

RTX proteins: a highly diverse family secreted by a common mechanism

Irena Linhartová, Ladislav Bumba, Jiří Mašín and 9 more

FEMS Microbiology Reviews · 2010 · Review

doi:10.1111/j.1574-6976.2010.00231.x

Abstract

Repeats-in-toxin (RTX) exoproteins of Gram-negative bacteria form a steadily growing family of proteins with diverse biological functions. Their common feature is the unique mode of export across the bacterial envelope via the type I secretion system and the characteristic, typically nonapeptide, glycine- and aspartate-rich repeats binding Ca(2+) ions. In this review, we summarize the current state of knowledge on the organization of rtx loci and on the biological and biochemical activities of therein encoded proteins. Applying several types of bioinformatic screens on the steadily growing set of sequenced bacterial genomes, over 1000 RTX family members were detected, with the biological functions of most of them remaining to be characterized. Activities of the so far characterized RTX family members are then discussed and classified according to functional categories, ranging from the historically first characterized pore-forming RTX leukotoxins, through the large multifunctional enzymatic toxins, bacteriocins, nodulation proteins, surface layer proteins, up to secreted hydrolytic enzymes exhibiting metalloprotease or lipase activities of industrial interest.

Shown for reading. Its publisher allows quoting it, not republishing it.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 17, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

With molecular cloning and DNA sequencing taking grounds in bacteriology labs, it has become clear since 1987 that a novel family of large secreted cytolytic toxins of Gram-negative pathogens emerged. Summarizing the similarities of the first five characterized determinants in a seminal MicroReview in 1991, Rodney A. Welch first introduced the concept of the RTX family of proteins characterized by the presence of arrays of glycine- and aspartate-rich nonapetide repeats. He predicted that this was a broadly disseminated family, while at that time it was difficult to imagine how broad and variable it could be.

RTX proteins are produced by a variety of Gram-negative bacteria and exhibit two common features. The first is the presence of repetitions of glycine- and aspartate-rich sequences, typically nonapeptides, which are located in the carboxy-terminal portion of the protein. These form numerous sites for the binding of Ca2+ ions and are at the origin of the historical name of the protein family, where RTX stands for repeats in toxin. The second key feature is the unique mode of secretion of RTX proteins via the type I secretion system (TISS). Protein translocation occurs through an oligomeric secretion channel spanning across the entire Gram-negative bacterial cell envelope (i.e. cytoplasmic membrane, periplasmic space and outer membrane). These dedicated ATP-binding cassette (ABC) transporter-based secretion apparati recognize uncleavable C-terminal secretion signals and mediate a single-step translocation of the RTX polypeptides from bacterial cytosol across both the inner and the outer bacterial membrane, directly into the extracellular space and without a periplasmic secretion intermediate. The rtx genes and genes needed for secretion are mostly located within a single larger rtx locus.

RTX proteins represent a family of proteins that exhibit a wide range of activities and molecular masses from 40 to >600 kDa. A prominent and historically first described group of RTX proteins consists of toxins, mostly exhibiting a cytotoxic pore-forming activity, often first detected as a hemolytic halo surrounding bacterial colonies grown on blood agar plates.

While the word ‘toxin’ is, for historical reasons, embodied in the name of the RTX protein family, a broad class of RTX proteins also comprises secreted proteases and lipases. These can act as synergistic virulence factors causing tissue damage and/or by eliciting the production of inflammatory mediators. Recently, a subgroup of very large RTX proteins (>3200 amino acid residues) with multiple activities [multifunctional autoprocessing RTX toxins (MARTX)] was discovered. For example, the prototype Vibrio cholerae MARTXVc was shown to cause rounding of epithelial cells by catalyzing covalent cross-linking of cellular actin. RTX proteins can further act as bacteriocins or contribute to defense against environmental aggression by forming protective bacterial surface (S)-layers. Some RTX proteins were also found to play a role in plant nodulation or Cyanobacteria motility, while the biological role of most RTX proteins remains unknown. Bioinformatic mining of the explosively growing database of bacterial genomes indicates that RTX proteins form a large and diverse family of proteins, with a broad spectrum of biological and biochemical activities.

RTX repeats

The requirement for calcium ions in RTX toxin activities was first documented for Escherichia coliα-hemolysin and Bordetella pertussis CyaA. Binding of calcium ions to the repeats of RTX toxins occurs only upon secretion, as the intracellular cytoplasmic calcium concentration in bacteria is quite low (<100 nM). The RTX protein needs to unfold or remains in a floppy conformation before translocation out of the cell through the TISS. Calcium binding to the nonapeptide repeats in the C-terminal portions of these toxins then appears to promote folding and imposes adoption of a functional conformation on the secreted RTX proteins in the extracellular environment.

Analysis of the three-dimensional structure of Pseudomonas aeruginosa alkaline protease possessing six of the RTX motifs with a consensus sequence X-(L/I/F)-X-G-G-X-G-(N/D)-D, where X means any residue, revealed that the repeated sequences constitute a new type of calcium-binding structure (Fig. 1), called a parallel β-helix or a parallel β-roll. In this structure, the first six residues of each motif form a turn that binds calcium, and the remaining three residues build a short β-strand. The arrangement of consecutive turns and β-strands builds up a right-handed helix of parallel β-strands, where one turn of this helix consists in two consecutive nonapeptides. Calcium is then bound within two consecutive turns by the conserved aspartic acids.

The numbers of RTX repeats vary among RTX proteins from <10 to >40. While RTX proteases and lipases typically have a single block of seven to eight RTX nonapeptide repeats, very extensive RTX repeat domains were found recently in the large MARTX or in putative RTX proteins encoded in some sequenced genomes. Somewhere in the middle between the extremes is the RTX domain of CyaA from B. pertussis. For example, this is organized in five successive blocks, containing about eight nonapeptide RTX motifs each, which are separated by linkers of variable lengths. The repeat domain of CyaA was then shown to harbor a small number (three to five) of high-affinity (Kd<1 nM) and about 40 low-affinity (Kd∼0.5–0.8 mM) binding sites for Ca2+ ions.

TISS

Gram-negative bacteria have evolved several (I–VI) pathways for protein secretion beyond the outer membrane to the extracellular environment (for reviews, see;;). The RTX proteins contain an ∼60-residue-long C-terminal secretion signal that is not processed during secretion. This is recognized by the sec-independent TISS, which mediates the translocation of proteins directly from the cytoplasmic compartment into the extracellular space through a channel spanning the entire cell envelope (Fig. 2).

Type I secretion across the cell wall depends on three specific proteins: a polytopic inner membrane protein with a cytoplasmic ATPase domain operating as an ABC exporter, a membrane fusion protein (MFP) and an outer membrane protein (OMP). The MFP spans out from the inner membrane into the periplasm and contacts both the inner membrane ABC exporter and the OMP. The paradigm of the type I secretion pathway is based on the analysis of the mechanism of secretion of the E. coliα-hemolysin (HlyA). The Hly exporter was also shown to promote to some extent the secretion of a number of heterologous RTX proteins expressed in E. coli, including the CyaA of B. pertussis, LtkA of Aggregatibacter (formerly Actinobacillus, Haemophilus) actinomycetemcomitans, PaxA of Pasteurella aerogenes or FrpA of Neisseria meningitidis.

The hlyCABD operon (Fig. 3a) codes for the toxin activation protein (HlyC), the hemolysin itself (HlyA), the ABC transporter (HlyB) and the MFP protein (HlyD). The outer membrane component (TolC), a multifunctional protein, is encoded outside of the hly operon on E. coli chromosome and is part of the mar-sox regulon. In some other species, however, the gene for a TolC homologue, such as cyaE of B. pertussis, is comprised in the rtx operon. TolC forms a trimeric export channel in the outer membrane and its presence plays a critical role in type I protein secretion.

The structure of TolC was determined by X-ray crystallography. It has been proposed that the trimeric accessory protein HlyD forms a substrate-specific complex with the inner membrane protein HlyB, which subsequently recognizes the C-terminal signal peptide of HlyA. Upon binding of HlyA, the HlyD trimer interacts with the trimeric TolC protein of the outer membrane, inducing its conformational change and export of HlyA. This complex appears to be transient, with the inner membrane complex of HlyB, HlyD and TolC disengaging and reverting to a resting state once the substrate has been transported. The energy necessary for the secretion process depends not only on ATP hydrolysis mediated by HlyB but also on the proton motive force on the inner membrane.

However, the work on secretion of Serratia marcescens hemoprotein HasA and Erwinia chrysanthemi metalloproteases B and C indicated a slightly different order of events, where the ABC transporter and MFP would associate only upon substrate binding.

It is generally assumed that type I secretion involves the translocation of unfolded proteins. Secretion of the HasA protein of S. marcescens was, indeed, shown to depend on the binding of the chaperone SecB. Moreover, HasA cannot be transported if allowed to fold in the cytoplasm. Intriguingly, contact with HlyD was suggested to affect directly or indirectly the folding of HlyA following or during its transit through the translocator.

An atypical TISS has been described for the large MARTX proteins in Vibrio. Here, the apparati consists of four proteins, an analogue of HlyB (RtxB), an analogue of HlyD (RtxD), a TolC-like protein and an additional ATP-binding protein RtxE, where both ABC exporter proteins, RtxB and RtxE, appear to be necessary for MARTX protein secretion.

A gene for a TolC-like OMP is also present in the protease and lipase secretion loci, but is absent from most other operons encoding the RTX toxin family TISS, except for B. pertussis (cya) or Moraxella bovis (mbx) loci. A unique genetic organization of TISS for RTX proteins was revealed in N. meningitidis. In contrast to the cistronic organization of the secretion genes for most other rtx operons, homologues of hlyD and tolC genes are flanked by genes normally associated with mobile genetic elements and do not form an operon with the hlyB gene. Furthermore, the three genes were shown to be expressed independently and mutation at either locus resulted in the inability to secrete the FrpC and FrpC-like (FrpC2) RTX proteins.

Initially, the gene encoding a TolC homologue had not been recognized in the genomes of A. actinomycetemcomitans HK1651 (http://www.genome.ou.edu/act.html) and Mannheimia haemolytica PHL213., however, found an ORF in A. actinomycetemcomitans that encodes the TdeA protein of predicted structural properties similar to TolC and showed that inactivation of the tdeA gene resulted in a mutant unable to secrete LtxA.

RTX cytotoxins

Cytotoxic RTX proteins are produced by a broad range of Gram-negative pathogens (Table 1) including the genera Escherichia, Bordetella, Proteus, Morganella, Moraxella, Vibrio and Kingella, and members of the Pasteurellaceae family (Mannheimia, Pasteurella and Aggregatibacter). RTX cytotoxins can be roughly divided into two families: the conventional and broadly studied pore-forming leukotoxins and the more recently discovered very large MARTX. The best-studied prototype of the MARTX group is VcRtxA (or MARTXVc) from V. cholerae, an over 4500-amino-acid-residue-long protein, which causes depolymerization of F-actin stress fibers in a broad range of cell types.

Pore-forming RTX cytotoxins

Pore-forming RTX cytotoxins represent a unique class of bacterial proteins that share (1) the requirement for post-translational activation through amide-linked fatty acylation of internal lysine residues; (2) possess a hydrophobic domain that was shown or is presumed to form cation-selective pores in target cell membranes; (3) are exported by TISSs; and (4) upon secretion are activated for exerting biological activity by binding calcium ions within the acidic glycine- and aspartate-rich nonapeptide repeats.

Based on the most obvious and/or historically first characterized activity, RTX toxins were divided into hemolysins and leukotoxins. The so-called RTX ‘hemolysins’ were initially found to exhibit a limited target cell and species specificity, while the activity of leukotoxins was considered to be species and cell-type specific. For example, E. coliα-hemolysin (HlyA) appears to be rather promiscuous, exhibiting a well-detectable cytotoxic activity on a wide spectrum of cells from various species, including erythrocytes, granulocytes, monocytes, endothelial cells or renal epithelial cells from mice, ruminants and primates. In turn, the leukotoxins of A. actinomycetemcomitans (LtxA) and M. haemolytica (LktA) appear to be quite selective and cytotoxic only to a restricted group of cell types in a species-specific manner.

However, this traditional classification as ‘hemolysins’ (pore-forming cytolysins) and leukotoxins appears to be somewhat obsolete. Even the ‘promiscuous’α-hemolysin of E. coli (HlyA) and the ‘hemolytic’ adenylate cyclase (AC) toxin (CyaA) of Bordetella were now found to preferentially bind and target leukocytes expressing the β2-integrins LFA-1 and Mac-1, respectively. It appears more appropriate to assume that all pore-forming RTX toxins are primarily leukotoxins, with selectivity for leukocytes being, at least for some of them, eroded at supraphysiological toxin concentrations. The residual activity of the most potent cytolytic (pore-forming) leukotoxins, with a less narrow host spectrum, would then be readily detected as cytolytic activity towards a broader variety of cell types, including erythrocytes. In contrast to these ‘hemolysins,’ the true ‘leukotoxins’ would lack any obvious activity on other cell types other than leukocytes from a certain host species.

Post-translational activation of RTX cytotoxins by covalent fatty acylation

The cytolytic (pore-forming) RTX leukotoxins are synthesized as inactive protoxins that undergo post-translational activation before export from the toxin-producing bacteria. This consists in post-translational modification of ɛ-amino groups of internal lysine residues within conserved acylation sites by covalent attachment of amide-linked fatty acyl residues (Fig. 3b). This reaction is catalyzed by the RtxC acyltransferases expressed together with the protoxins. The mechanism of this novel type of protein acylation was analyzed in substantial detail for the prototype RTX toxin-activating and acyl-ACP-dependent protein acyltransferase HlyC, which converts the E. coli proHlyA to mature α-hemolysin toxin HlyA. HlyC uses the fatty acyl residues carried by acyl-ACP to form a covalent acyl-HlyC intermediate, which transfers the fatty acyl residues to the ɛ-amino groups of Lys564 and Lys690 residues of proHlyA. Several residues, including Ser20 and His23, were identified as being potentially involved in the catalysis of acyl transfer by HlyC. Acyl-ACPs carrying various fatty acyl residues, including the palmitic (C16:0) and palmitoleic (C16:1) residues most common in E. coli, could be efficiently used in vitro as acyl donors for modification of HlyA, while acyl-CoA is not used as a substrate by HlyC. In vivo, however, HlyC exhibits a high selectivity for C14:0 myristic acid, which was found to constitute about 68% of the acyl chains covalently linked to Lys564 and Lys690 of native HlyA. Surprisingly, the extremely rare odd carbon-saturated C15:0 and C17:0 fatty-acyl residues were found to constitute the rest of the in vivo acylation of HlyA from two different clinical E. coli isolates. The biological relevance of the use of odd-carbon acyl residues for activation of HlyA as well as the mechanism by which HlyC selects these acyl-ACP loaded by the extremely rare acyl residues remains to be clarified.

The role of acylation in toxin activity was analyzed for B. pertussis CyaA, where the extent of fatty acylation in vivo was found to depend on the producing strain. Initially, the Bp-CyaA extracted from a Tohama I-type B. pertussis 338 was found to be monoacylated by a single palmitoylation at the Lys983 residue only. Further work confirmed that the acylation of Lys983 was necessary and sufficient for the activation of CyaA. The CyaA sequence, however, comprises two characteristic acylation sites conserved in the RTX cytolysin family, suggesting that CyaA can also be acylated on a second lysine residue, Lys860. The recombinant r-Ec-CyaA toxin produced in the presence of CyaC in E. coli was, indeed, found to bear a second acylation at Lys860. Moreover, recombinant r-Bp-CyaA protein overproduced by a B. pertussis 18323/pBN strain was also later found to be acylated on both Lys860 and Lys983 residues. The reduced specific hemolytic activity of r-Ec-CyaA was then attributed to the modification by mainly the unsaturated palmitoleic (cisΔ9 C16:1) fatty-acyl groups when produced in E. coli, while exclusively saturated C16:0 palmityl residues were found attached to Bp-CyaA in B. pertussis. Furthermore, acylation of each of the Lys860 or Lys983 residues alone was necessary and sufficient for conferring CyaA a full capacity to tightly bind its αMβ2 integrin receptor (CD11b/CD18). The mutant CyaA-K983R, acylated only on Lys860, still exhibited a fairly high (∼20%) cytotoxic activity towards murine monocytic cells expressing CD11b/CD18, when compared with CyaA-K860R mutant monoacylated on the Lys983 residue alone, or to intact r-Ec-CyaA acylated on both Lys860 and Lys983 residues. Acylation of Lys983 appears, in turn, to be absolutely essential for the residual cytolytic activity of CyaA on cells lacking CD11b/CD18.

Pore-forming RTX toxins require fatty acylation for all known cytotoxic activities. However, the exact role of the post-translational modification in the mechanism of action is not truly understood. The nonacylated proHlyA and proCyaA form pores in planar lipid bilayers with a much reduced propensity, but the formed pores have quite similar properties as the pores generated by acylated toxin. Both nonacylated proHlyA and proCyaA are also quite active in penetrating a naked liposome membrane, suggesting that the acyl residues are not essential for toxin penetration into the membrane lipid bilayer. Recent evidence indicated that fatty-acylation status and nature may modulate toxin oligomerization and is essential for productive binding of RTX toxins to target cell receptors, allowing the cytotoxic action to occur.

Pore-forming activity and interaction with the cell membrane in the absence of a specific cell receptor

The highly potent and less specific cytolytic RTX leukotoxins, such as E. coli HlyA or Bordetella CyaA, also exhibit a readily detectable activity on cells other than leukocytes. Their interaction with the target cell membrane devoid of a specific proteinaceous receptor appears to occur in two steps, starting with a reversible adsorption of the toxin that is sensitive to electrostatic forces, which is then followed by an irreversible membrane insertion. Adsorption of RTX toxins is detectable on both toxin-sensitive cells and on certain toxin-resistant cells. Studies with the isolated calcium-binding domain of HlyA revealed that this part of the protein may adsorb on the membrane in the early stages of HlyA–membrane interaction. Recent results with CyaA, HlyA and LtxA showed that these toxins exhibit a weak lectin activity and recognize and bind the N-linked oligosaccharides of their β2 integrin receptors. This raises the possibility that the initial unsaturable binding of RTX cytotoxins to various cells might occur through the recognition of glycosylated membrane components, such as glycoproteins and gangliosides.

Whether proteinaceous receptors are involved in binding of RTX toxins to cell types other than leukocytes remains an open question. For example, earlier dose–response binding assays indicated an upper limit of 4000 HlyA binding sites per erythrocyte, implying at least some degree of specificity., however, did not observe any saturability of binding of HlyA to erythrocytes, suggesting that binding was receptor independent. These data are compatible with later observations of,, showing that HlyA can use the abundant glycophorin protein as a high-affinity receptor on erythrocytes. HlyA binding and action on erythrocytes was blocked by antibodies binding glycophorin, by a competing peptide comprising residues 914–936 of HlyA or upon glycophorin digestion with trypsin.

Once HlyA has inserted into the cell membrane, it appears to undergo an irreversible conformational change, after which it cannot be recovered from the membrane without the use of detergents. However, the mechanism of membrane insertion and pore formation by RTX toxins remains poorly understood. Several studies confirmed that the hydrophobic domain of the N-terminal half of the pore-forming RTX leukotoxins is critical for their ability to form transmembrane pores. Other studies also showed that the hydrophobic region of E. coli HlyA was responsible for the insertion of the toxin into the target membrane. Biophysical studies demonstrated that RTX toxins form cation-selective pores of a defined size and with short lifetimes of only a few seconds. At higher toxin concentrations, however, these pores may change subunit stoichiometry over time and aggregate into larger lesions in the cell membrane.

Whether pore formation by the RTX leukotoxins depends on the toxin oligomerization step remained a matter of controversy. HlyA has been recovered from target membranes only as a monomer. On the other hand, the dose–response analyses indicated that the lytic activity on target cells was a highly cooperative function of toxin concentration, suggesting that oligomerization was involved in RTX toxin pore formation. Moreover, in vitro complementation within pairs of individually inactive deletion variants of E. coli HlyA or B. pertussis CyaA allowed to restore, at least in part, the hemolytic and cytotoxic activities, suggesting that two or more toxin molecules had aggregated to form a pore. This substantiated the view that oligomerization was involved in pore formation by HlyA or CyaA. Recent results obtained with CyaA revealed the presence of rather unstable (dynamic stoichiometry) CyaA oligomers in the erythrocyte membrane, revealing a correlation between oligomerization of CyaA mutants in the membrane and their pore-forming capacity.

Binding through cell-specific receptors

Recently, it has become increasingly clear that even the more ‘promiscuous’ RTX leukotoxins bind leukocytes through specific proteinaceous receptors of the β2 integrin family. For example, CyaA of B. pertussis was shown to use the αMβ2 (CD11b/CD18) integrin (known also as a complement receptor 3 or Mac-1) as a target-cell specific receptor. HlyA of E. coli was also found to specifically bind leukocytes and to interact with the β2 integrin CD11a/CD18 at low concentrations. Other studies, however, indicated that the binding of HlyA to cells occurred in a nonsaturable manner and the toxin did not interact with a specific protein receptor on granulocytes. These contradictory results await definitive clarification and it is possible that too low concentrations of HlyA were used in the latter study and saturation of the abundant CD11a receptor was not reached. Moreover, A. actinomycetemcomitans and M. haemolytica leukotoxins (LtxA and LktA, respectively) are specific for human and bovine leukocytes, respectively, and were also found to interact with CD11a/CD18. The initial interaction of RTX leukotoxins with β2 integrins then appears to rely on the recognition of N-linked glycans, as revealed for A. actinomycetemcomitans LtxA, E. coli HlyA and B. pertussis CyaA.

Elevation of calcium concentration in target cells

Elevation and modulation of free cytosolic calcium concentrations are basic strategies of host cell manipulation by pathogens. Cytosolic calcium levels are tightly controlled and their modulation is part of most prominent cellular signalling pathways that regulate many cellular processes. The initial observation that HlyA of E. coli was responsible for significant calcium influx into cells was made by. This was corroborated by demonstrating that pore-forming RTX toxins, such as M. haemolytica LktA, A. actinomycetemcomitans LtxA or B. pertussis CyaA, also caused unregulated calcium influx into target cells. It has even been proposed that cell killing by RTX toxins was due to unregulated calcium influx, which would initiate cytoskeletal destruction and cell lysis. This mechanism may underlie the action of A. actinomycetemcomitans LtxA that was reported to promote Ca2+ changes in T-cells and to initiate a series of events that involve the activation of calpain, talin cleavage, mobilization of β2 integrin molecules into membrane lipid rafts and subsequent cell lysis. Other findings indicate that the calcium influx induced by sublytic doses of RTX toxins accounts for the induction of inflammatory responses.

There persists, nevertheless, a controversy on the mechanisms by which specifically the RTX family of toxins would promote calcium influx into cells. reported that sublytic doses of E. coli HlyA stimulated oscillatory calcium responses in renal epithelial cells through the activation of L-type voltage-gated calcium channels and the subsequent response of IP3 receptor channels in the endoplasmic reticulum. Moreover, M. haemolytica LktA appears to increase the cytoplasmic Ca2+ concentration in bovine alveolar macrophages and neutrophils both by the influx of extracellular Ca2+ through voltage-gated channels as well as by promoting the release of Ca2+ from stores in the endoplasmic reticulum. However, working with different concentrations of HlyA on different cell lines, others have reported that HlyA induces an increase in cytoplasmic [Ca2+]c by allowing a passive influx of Ca2+ into cells through toxin pores. Moreover, reported that B. pertussis CyaA caused an increase of [Ca2+]c in monocytic cells by a mechanism that is independent of its pore-forming activity or of Ca2+ release from intracellular stores and depends on membrane translocation of the N-terminal cell-invasive domain polypeptide, but not on its enzymatic activity. The translocating AC domain, as such, appears, indeed, to participate in the formation of a novel and transient Ca2+ influx path in the host cell membrane.

These seemingly contradictory results may be reconciled in part by the observed positive feedback effect on initial cell membrane permeabilization due to toxin insertion. As shown for HlyA, ATP leakage and Ca2+ influx, accompanying membrane insertion of HlyA, induces the activation of purinergic receptors and pannexin channels that are permeable for monovalent cations and Ca2+. This further potentiates the influx of extracellular Ca2+ and contributes to cell lysis.

Broadly cytolytic RTX leukotoxins (hemolysins)

RTX leukotoxins are typically produced by Gram-negative pathogens and commensals of respiratory, gastrointestinal or reproductive tracts or oral cavities of animals and humans. The characterized broadly cytolytic RTX leukotoxins, thus far classified as ‘hemolysins’, are listed in Table 1. These toxins exhibit a hemolytic activity in vitro that is revealed by cultivating corresponding bacteria on sheep blood agar plates. In vivo, these toxins induce the production of inflammatory mediators or display cytotoxic and cytolytic effects on host immune cells of different species, thus inducing necrosis, apoptosis and inflammation.

HlyA of E. coli

Among the best-characterized RTX ‘hemolysins’ is HlyA, the single polypeptide (107 kDa) α-hemolysin secreted by uropathogenic as well as many commensal fecal isolates of E. coli (Fig. 3). The N-terminal 200 amino acid hydrophobic domain of HlyA is predicted to contain nine amphipathic α-helices, while the C-terminal Ca2+-binding domain contains 11–17 of the glycine- and aspartate-rich nonapeptide β-strand repeats (depending on the stringency of the criterium for consensus motif conservation). It is assumed that membrane interaction of HlyA occurs mainly through the amphipathic α-helical domain. However, it has been proposed recently that both major domains of HlyA are directly involved in the membrane interaction of HlyA, the Ca2+-binding domain being responsible for the early stages of HlyA docking to the target membrane. Similarly, showed that both the pore-forming and the acylation domain of CyaA are required for membrane interaction. observed that a short sequence from the C-terminal domain (amino acid 914–936) was the main HlyA segment binding theα-glycophorin on erythrocytes.

A homologous EhxA protein is produced by the enterohemorrhagic E. coli O157:H7 from a gene located on a 90 kbp plasmid (pO157). EhxA exhibits 61% identity to HlyA, but displays a more narrow target cell specificity and binds erythrocytes less efficiently, exhibiting virtually no activity against human leukocytes.

MmxA, MbxA and PvxA of Enterobacteriaceae and MbxA of Moraxellaceae

‘Hemolysins’ homologous to HlyA were identified by as MmxA of Morganella morganii and PvxA of Proteus vulgaris, where MmxA also exhibited cytotoxic activity towards human polymorphonuclear leukocytes.

The MbxA secreted by M. bovis is implicated in the pathogenesis of infectious bovine keratoconjunctivitis, where it promotes corneal epithelial cell damage. The mbxCABD genes form a classical rtx operon that is absent from nonhemolytic strains and is part of a mobile genetic element designated as a pathogenicity island of M. bovis.

ApxIA, ApxIIA, ApxIIIA, AqxA and PaxA of Pasteurellaceae

A large group of homologous cytolytic RTX ‘hemolysins’ is secreted by bacteria of the genus Pasteurellaceae. These include ApxIA, ApxIIA, ApxIIIA of Actinobacillus sp. and AqxA of Actinobacillus equuli or PaxA of Pasteurella aerogenes. In fact, genetic analysis suggests that RTX determinants might have evolved in Pasteurellaceae and spread to other Gram-negative bacteria by horizontal gene transfer.

Studies involving apx deletion mutants and trans-complementation experiments show that ApxIIA is essential in the pathogenesis of porcine pleuropneumonia and that the combination of ApxIA and ApxIIA, secreted by certain serotypes of Actinobacillus pleuropneumoniae, accounts for the severe course of the disease with a fatal outcome. The ApxIIIA protein as well as PaxA of P. aerogenes are nonhemolytic on erythrocytes, but show a significant CAMP reaction, a cohemolytic reaction dependent on the sphingomyelinase from β-hemolytic Staphylococcus aureus. ApxIIIA was shown to be highly cytotoxic against macrophages and was previously called the macrophage toxin. The cytotoxic activity of PaxA, also produced by Pasteurella mairi, has not yet been analyzed in detail, but all P. aerogenes and P. mairi isolated from aborted feta or neonatal septicemia of pigs produced PaxA, while strains devoid of the paxA gene are isolated as opportunistic pathogens or commensals. In general, there are little molecular and functional data available on the role in virulence and host or target cell specificity of most of the RTX toxins from animal pathogens.

Species-specific RTX leukotoxins

The sensu stricto RTX leukotoxins appear to be active only on a restricted group of cell types in a species-specific manner. For example, the biological effect of LktA produced by M. haemolytica is largely restricted to ruminant leukocytes and platelets, whereas A. actinomycetemcomitans LtxA only kills lymphocytes and granulocytes from humans, the Great Apes and Old World monkeys. Both LktA and LtxA, however, also exhibit a detectable hemolytic activity on erythrocytes.

LktA plays a role in the pathogenesis of bovine and ovine pneumonic pasteurellosis, whereas A. actinomycetemcomitans LtxA is the main virulence factor of localized aggressive periodontitis in humans. These toxins can inhibit the mobility, chemotaxis and respiratory burst of neutrophils, release inflammatory mediators from granulocytes or macrophages, prevent phagocytosis by polymorphonuclear cells and disrupt the phagosome, thus allowing bacterial invasion of the phagocyte. Altogether, these effects strongly reduce the immune response of the host. The A. actinomycetemcomitans LtxA was further reported to interact with Cu, Zn superoxide dismutase, which may protect both the bacteria and the LtxA from reactive oxygen species produced by host inflammatory cells.

Cytolytic RTX leukotoxins (Table 1) are proteins of a typical molecular mass of 100–120 kDa that possess similar structural and functional domains and are encoded within similar rtx operons as the RTX ‘hemolysins’ (Fig. 3). LtxA shares 40–50% amino acid homology with the E. coli HlyA and M. haemolytica LktA. Similarly, both the nonacylated proLktA and proLtxA were in turn able to bind target cells without increasing the intracellular calcium concentration or inducing cytolysis. The proLktA can be acylated to mature LktA by E. coli HlyC, Bordetella CyaC and Actinobacillus LtxC. Substitution of Lys-554 to Thr or Cys reduced the lytic activity of LktA against bovine lymphocytes by only 40%, indicating the presence of a second functionally redundant acylation site. Recently, two internal lysine residues of A. actinomycetemcomitans LtxA (Lys-562 and Lys-687) have been identified as targets for covalent fatty acid modification by the ltxC gene product. Interestingly, LtxA is the only RTX toxin that has a basic pI of 8.9. Also, the RTX domains of both LktA and LtxA are shorter than that of HlyA and contain only seven and eight calcium-binding nonameric repeats, respectively. Their hydrophobic domain in the N-terminal part was proposed as the region that spans the target cell membrane and deletions in this region impair the cytolytic and pore-forming activities. While the region of LtxA required for the recognition of human target cells appears to span the glycine-rich repeats, the segment determining specificity for ruminant cells has been associated with the N-terminal portion of LktA.

The production of leukotoxins is increased under anaerobic conditions and is regulated by environmental cues, such as the availability of iron, temperature, sugar levels and the concentration of signalling molecules of the quorum-sensing system.

A difference in the release of LtxA into the culture medium and retention on the cell surface was observed between nonadherent (smooth) and adherent (rough) strains of A. actinomycetemcomitans and LtxA release into the medium could be related to mutations in the tad gene involved in the tight nonspecific adherence of A. actinomycetemcomitans. Recently, A. actinomycetemcomitans LtxA was also found to be released within outer-membrane vesicles. These are likely to deliver LtxA to host cells, similar to the delivery of E. coli heat-labile enterotoxin into mammalian cells.

The quite narrow host range of leukotoxins appears to be due to cell-specific binding through the β2 integrins. The requirement for β2 integrins in cytotoxic action was first observed for M. haemolytica LktA, which was not cytotoxic to neutrophils isolated from animals suffering from a bovine leukocyte adhesion deficiency. This deficiency is due to a single point mutation (D128G) in the highly conserved extracellular region of the CD18 subunit, which results in reduced membrane expression of the β2 integrin LFA-1. In fact, the β2 integrins share a common β2 subunit, CD18, which is combined with either one of the unique α chains, αL (CD11a), αM (CD11b), αX (CD11c) or αD (CD11d). So far, two of these integrins have been found to bind RTX leukotoxins: αLβ2 integrin, known as lymphocyte function-associated antigen 1 (LFA-1, CD11a/CD18), was shown to bind HlyA, LktA and LtxA, and the αMβ2 integrin binds Bordetella CyaA, respectively. Transfection of an LFA-1-expressing construct rendered an otherwise resistant K562 cell line sensitive to killing by LtxA. Recently, explained the species selectivity of LtxA by showing that it recognizes the N-terminal 128 amino acid residues of human CD11a that are missing in the murine LFA-1 counterpart. However, the cysteine-rich tandem repeats of the human CD18 subunit were also reported to interact with LtxA.

The CD18 subunit of bovine β2 integrins was, in turn, identified as the receptor for M. haemolytica LktA. Expression of either bovine LFA-1 or chimeric LFA-1 (bovine CD18/murine CD11a) rendered the LktA-resistant cells susceptible to LktA, with the magnitude of LktA-induced cytotoxicity correlating with the levels of LFA-1 expression on the target cell surface. It remained, however, controversial as to which part of the CD18 subunit LktA binds, as mapped it within amino acids 1–291, while, found it between residues 541 and 581 of the extracellular region of bovine CD18. Nevertheless, have recently shown that the LktA-binding site is formed by amino acids 5–17 of CD18, which, surprisingly, comprise most of the amino acids of the signal peptide that remains intact on mature CD18 molecules on the cell surface.

Leukotoxin activities against target cells are highly dose dependent. At sublytic concentrations, leukotoxins induce an increase in [Ca2+]c in cells and activate neutrophils and mononuclear cells to undergo oxidative burst and degranulation. This is accompanied by the production of several lipid mediators and proinflammatory cytokines from human macrophages. Pulmonary mast cells were shown to release histamine in response to LktA and LktA has also been shown to inhibit bovine lymphocyte blastogenesis induced by concanavalin A and pokeweed mitogen. Mannheimia haemolytica LktA also affects the adhesion of platelets, which gives rise to fibrin deposits in lung alveoli of cattle with pasteurellosis. As the concentration of leukotoxins increases, target cells are stimulated to undergo apoptosis, involving LFA-1 signalling through protein kinase C and adverse effects on the mitochondria. At higher leukotoxin concentrations, the apoptotic mechanisms are exceeded and necrosis occurs due to pore formation. LktA-mediated cell permeabilization was shown to cause a rapid leakage of the intracellular potassium and cell swelling. In vitro studies showed that LtxA formed voltage-gated ion channels of large conductance in the planar lipid bilayer, with an approximate functional diameter of 0.96 nm. A pore size of about 1.2 nm was, in turn, deduced for LktA from osmotic protection experiments with raffinose. In addition, metabolites from phospholipase C activation (arachidonic acid) appear to contribute to LktA-induced cytolysis significantly.

AC toxin – a bifunctional toxin with a cell-invasive enzymatic and pore-forming activity

The 1706-residue-long CyaA is unique among RTX leukotoxins by being a bifunctional toxin in which a cell-invasive AC enzyme domain (∼400 residues) has been fused to the N-terminus of a pore-forming RTX ‘hemolysin’ moiety (Fig. 3). This part of CyaA (∼1300 carboxy-proximal residues) consists of typical segments, such as (1) a hydrophobic pore-forming domain comprising residues 500–800; (2) an activation domain, where the post-translational palmitoylation of lysine residues 860 and 983 of CyaA occurs; and (3) a typical calcium-binding RTX domain, harboring the nonapeptide repeats of a consensus sequence X-(L/I/F)-X-G-G-X-G-(N/D)-D, which form numerous (∼40) calcium-binding sites.

CyaA primarily targets and paralyzes with high efficacy the leukocytes expressing the αMβ2 integrin (CD11b/CD18). With reduced efficiency, however, the toxin can also penetrate and deliver the AC enzyme into a variety of cells lacking the CD11b/CD18. Unlike most other enzymatically active toxins, which penetrate into cell cytosol from endosomes, several reports showed that the AC is delivered directly across the cytoplasmic membrane of cells without the need for receptor-mediated endocytosis of the toxin. In target cytosol, the N-terminal AC domain of CyaA binds intracellular calmodulin, whereupon its specific enzymatic activity is increased by ∼10 000-fold and catalyzes uncontrolled conversion of cellular ATP to cAMP, a key second messenger signalling molecule. This subverts the signalling of protein kinase A and essentially instantaneously ablates the bactericidal functions of phagocytes, such as oxidative burst and phagocytosis, and induces the secretion of immunomodulatory cytokines. Recently, the crystal structure of the AC domain of CyaA in the complex with the C-terminal fragment of calmodulin was resolved by.

The main segment of CyaA required for binding to the αMβ2 integrin was located in the glycine-rich repeat region between residues 1166 and 1281 of CyaA. However, cooperation and structural integrity of all domains of the ‘hemolysin’ moiety of CyaA appear to be critical for membrane insertion and translocation of the N-terminal AC enzyme domain into cell cytosol. Translocation itself, but not the mere insertion of CyaA into the cytoplasmic membrane of cells, is driven by a negative membrane potential. Fiser and colleagues showed that the translocating AC polypeptide inserted into the cell membrane participates in the formation of a novel type of membrane path for Ca2+ influx into monocytic cells. The latest results from our laboratory show that calcium influx induces talin cleavage by calpain and enables mobilization of CyaA with CD11b/CD18 into lipid rafts, where the cholesterol-enriched lipid environment supports the translocation of the AC domain across membrane. Moreover, translocation of the AC domain and oligomerization into cation-selective pores appear to represent two independent and parallel/competing activities of the membrane-inserted form of CyaA. Either activity can be upmodulated at the expense of the other by specific substitutions of key glutamate residues forming pairs in the predicted transmembrane segments between residues 500 and 700 of CyaA. These were found to play a critical role in cell binding, formation of cation-selective pores and translocation of the AC domain into the cells. The ‘hemolysin’ pores formed by CyaA have a diameter of only about 0.6–0.8 nm and the specific ‘hemolytic’ activity of CyaA is relatively low, compared with HlyA for example. It appears, nevertheless, to synergize with the invasive AC enzyme activity in maximizing the overall cytotoxic potency of the toxin on CD11b+ cells.

The role of CyaA in the interaction of Bordetella with cells of the respiratory epithelia and in the modulation of the host immune response through the induction of proinflammatory cytokine secretion remains poorly explored. Recent work has suggested that CyaA activity may account for the induction of IL-6 in tracheal epithelia colonized by B. pertussis. CyaA contributes to numerous pathological effects in the murine model of lung infection, such as efficient pulmonary colonization, induction of histopathological lesions in lungs, recruitment of inflammatory leukocytes and induction of lethality. Low concentrations (1–5 ng mL−1) of CyaA have recently been shown to effectively inhibit complement-mediated opsonophagocytosis, which is a crucial defense mechanism of naive unimmunized hosts. In fact, CyaA-mediated intoxication by cAMP was also found to inhibit the phagocytosis of B. pertussis cells via Fc receptors by neutrophils. CyaA activity further causes a loss of chemotactic and oxidative burst capacities required for the bactericidal activity of leukocytes. Moreover, the toxin can induce macrophage apoptosis by a mechanism involving disruption of the membrane potential of mitochondria. In many Bordetella isolates, the CyaA protein remains attached to the bacterial surface following secretion, due to interaction with the filamentous hemagglutinin. Most of the cell-attached CyaA appears, however, to be aggregated and unable to act as a ‘contact weapon’, because only the newly secreted CyaA was found to be capable of penetrating target cells and increasing the intracellular cAMP levels.

Use of CyaA in research and vaccine applications

Because Gram-negative bacteria generally do not express calmodulin homologues and the AC domain exhibits only residual enzyme activity in the absence of calmodulin, the AC domain of CyaA could elegantly be used as a reporter enzyme for tracing protein translocation into the eukaryotic cell cytosol. The AC (Cya) reporter protein is fused to an effector protein secreted through the type III secretion pathway (TTSS), such as the Yersinia Yop proteins. While the fusion exhibits only very low AC enzyme activity in the bacterial cell and/or the culture supernatants, once it is injected through the TTSS pathway into a eukaryotic host cell, the AC enzyme is activated >1000-fold by host calmodulin and catalyzes the rapid conversion of ATP to cAMP. Use of the AC (Cya) fusion reporter has now become a standard technique for the demonstration of contact-dependent direct translocation of TTSS effector proteins into animal and plant host cells by a number of Gram-negative species.

Another original application makes use of the fact that the residual activity of the AC domain in the absence of calmodulin requires the physical interaction of the T25 and T18 fragments of the AC domain. This could be well exploited to develop a bacterial two-hybrid system for the detection of protein–protein interactions. When the T25 and T18 fragments are individually fused to peptides or proteins that are able to bind each other, the interaction of the chimeric polypeptides brings together the T25 and T18 fragments, resulting in the restoration of a residual capacity of the enzyme to convert intracellular ATP to cAMP, even in the absence of eukaryotic calmodulin. This, in turn, can be monitored in a rather sensitive manner using E. coli hosts lacking the endogenous AC activity as indicator strains for the two-hybrid screening, because even very low levels of cAMP produced by the reconstituted AC enzyme will allow transcription of the genes involved in lactose and maltose catabolism in E. coli.

In another application, the genetically detoxified CyaA, unable to increase cAMP levels, could be exploited for highly efficient in vivo delivery of foreign T-cell epitopes into the major histocompatibility complex class I- and II-dependent antigen presentation pathways of CD11b+ dendritic cells. This allowed the use of CyaA for antigen delivery and induction of strong Th1-polarized and epitope-specific CD8+ cytotoxic T-cell responses, effective in prophylactic vaccination against viruses and in immunotherapy of certain tumors. Phase I/II human clinical trials aimed at exploring this exciting application of CyaA for cervical cancer and melanoma immunotherapy are currently in preparation.

MARTX

A quite different and recently discovered division of the RTX-toxin family is a group of very large toxins that differ from all previously known RTX proteins by the molecular structure and rtx gene cluster organization (Table 1, Fig. 3). These MARTX have thus far been identified in several different Vibrio species (Vibrio sp. RC385, V. cholerae, Vibrio splendidus, Vibrio anguillarum, Vibrio vulnificus) and are also present in Aeromonas hydrophila, Yersinia enterocolitica and Yersinia kristensenii, Proteus mirabilis, Photorhabdus luminescens and Photorhabdus asymbiotica (Supporting Information, Tables S1 and S2). The best-studied prototype of MARTX is the V. cholerae RtxA (VcRtxA), renamed to MARTXVc.

All rtxA-like MARTX genes encode proteins that range from 3212 to 5206 amino acid residues in length. In contrast to other toxins, the C-terminal repeats of MARTX proteins exhibit an 18-residue-long consensus sequence X(V/I)XXGXXNX(V/I)XXGDGXDX. These share a common G-7X-GXXN central motif, instead of the typical nonapeptide repeat. Moreover, MARTX proteins possess additional N-terminal repeats, which fall in two classes. The first has a 20-residue consensus sequence GXXG(N/D)(L/I)(T/S)FXGAG(A/G)XNX(L/I)X(RH) and the second has a 19-residue consensus T(K/H)VGDGX(S/T)VAVMXGXAN(I/V)X. Altogether, the glycine-rich repeats represent about 25% of the sequence of MARTXVc and were proposed to bind the eukaryotic cell surface and to facilitate the translocation of a central ∼1700 amino acid portion of the MARTXVc to the target cell cytosol. These central regions of MARTX are composed of differing activity domains that, upon entry into the eukaryotic cell, may exert different cytotoxic activities. However, except for the central domains of MARTXVc and part of V. vulnificus RtxA (MARTXVv), the biological activity and function of these large RTX proteins remain unknown. Little is known about the post-translational modifications of MARTX proteins. An rtxC gene similar to the hlyC acyltransferase gene required for maturation of E. coliα-hemolysin is located in the same operon with the rtxA gene. The recent data indicate that rtxC is not necessary for the MARTX toxin function in V. cholerae, but the MARTX toxin without rtxC activation showed reduced actin cross-linking activity, while a deletion of rtxC had no effect on the virulence of V. vulnificus. These results suggest that acylation may not be essential for all MARTX toxins.

Analysis of the available genomic structures revealed that the martx loci typically consist of two divergent operons (rtxHCA and rtxBDE). The toxin gene is found as the third gene downstream of the rtxC homologue (a putative acyl transferase) and a conserved hypothetical gene (rtxH) of unknown function, which is found only in the martx gene clusters. The divergent operon contains three more genes that encode homologues of the ATP-binding transporter protein RtxB, the MFP RtxD and a second ATPase, RtxE. The latter also appears to be involved in MARTX secretion by TISS, as rtxE gene disruption in V. vulnificus and V. anguillarum blocked the secretion of MARTXVv (MARTXVa, respectively) and induced a significant reduction in bacterial cytotoxic activity against epithelial cells in vitro. The necessary homologues of the OMP tolC are then found outside the rtx loci. This atypical four-component TISS seems to be a conserved feature across the entire MARTX family.

The production of MARTX TISS components is regulated by the growth phase. The repressor regulating rtxBDE expression is encoded outside the rtx locus and is not directly linked to quorum sensing, while V. cholerae may apparently couple the regulation of the rtx locus to the detection of stress. The rtxH, rtxC and rtxA genes are coordinately expressed on a single mRNA.

The prototype rtxA gene was found in both clinical and environmental isolates of V. cholerae, but not in the O1 classical biotypes. The deduced MARTXVc protein is 4545 residues long, with a predicted molecular mass of >485 kDa. In contrast to pore-forming RTX leukotoxins, the MARTXVc does not appear to disrupt membrane integrity or cause cell death. Rather, MARTXVc activity contributes to the severity of acute inflammatory responses in the pathology of cholera by inducing alteration of permeability of the paracellular tight junctions. This results from the capacity of MARTXVc to induce cell rounding and depolymerization of the actin cytoskeleton in a broad range of cell types, and yet the cells remain viable. Concurrent with actin stress fiber disassembly, actin monomers are covalently cross-linked into dimers, trimers and higher multimers by the actin cross-linking domain (ACD), which utilizes G-actin as a substrate and hydrolyzes one molecule of ATP per cross-linking event. The ACD of MARTXVc, located between residues 1963 and 2375, catalyzes a unique reaction consisting of the formation of an intermolecular iso-peptide bond between the γ-carboxyl group of glutamic acid residue 270 and the ɛ-amino group of lysine residue 50 of actin. Contrary to expectation, however, deletion of the ACD did not ablate the cell-rounding activity of MARTXVc, revealing that the large toxin carried a second cell-rounding activity. This targets the regulation of the small Rho GTPases, Rho, Rac and Cdc42, rather than the Rho GTPase proteins directly, and a 548-residue-long Rho inactivation domain (RID) of MARTXVc was recently found to inactivate the Rho GTPases by a mechanism distinct from other Rho-modifying bacterial toxins.

The MARTXVc toxin was found to insert into the host cell plasma membrane and is supposed to directly translocate the ACD to the cytosol of cells in a way involving insertion of the N- and C-terminal repeat regions into the cell membrane. Inside the cell, the ACD is released into cell cytosol through self-processing catalyzed by a conserved cysteine protease domain (CPD), which cleaves MARTXVc between residues L3428 and A3429. Three additional CPD-dependent processing sites were identified, all at leucine residues delimiting the ACD, RID and α/β junction domains. Autoprocessing of MARTXVc thereupon results in the release of individual activity domains into target cytosol. Autoprocessing activity of the CPD is induced by binding inositol hexakisphosphate (InsP6), which is abundant at the inner surface of the cell membrane, and the CPD activation mechanism was recently characterized in molecular detail. Because InsP6 is exclusive to eukaryotes and is present at cytosolic concentrations >10 μM, the evolution of a proteolytic biosensor responding to InsP6 appears to be an ingenious strategy for assuring that the functional activation of a secreted toxin occurs only once it has reached the host cell cytosol.

The sequence of the V. vulnificus RTX toxin (VvRtxA, MARTXVv) was reported in 2003, showing that it consists of 5206 residues and has a predicted molecular mass of 556 kDa. The deduced primary amino acid sequence of MARTXVv is ∼80–90% identical throughout most regions to that of MARTXVc. However, no ACD is present in MARTXVv, which also does not cause actin cross-linking and posesses only the Rho-inactivating activity associated with an RID. This is followed by a CPD located towards the C-end of MARTXVv.

Unlike MARTXVc, the MARTXVv may be able to disrupt membranes by the predicted segments homologous to those of pore-forming RTX toxins. This would go well with the difference in the virulence of the pathogens, where V. vulnificus is exceedingly more destructive and cytolytic, as compared to V. cholerae. Indeed, MARTXVv appears to be crucial for V. vulnificus virulence and cytotoxicity.

The RtxA of V. anguillarum appears to play a major role in the virulence of the agent causing vibriosis in fish. The rtx operon encodes a second hemolysin gene cluster in V. anguillarum M93Sm, which also has a hemolysin gene, vah1. While Vah1 causes cell vacuolation, the MARTXVa causes cell rounding. Analysis of the MARTXVa sequence reveals that the protein does not contain an ACD, but a homologue of the RID was identified. The contribution of the RID to cell rounding needs to be investigated further. Single mutations in vah1 or rtxA attenuate the cytotoxicity of V. anguillarum M93Sm and a vah1+rtxA double mutant is no longer cytotoxic.

The genes for MARTX homologues of P. luminescens are clustered in two chromosomal regions and are tandemly organized. There are four loci containing intact rtxA genes, while four are disrupted by frameshifts or insertion sequences. The organization of genes encoding the RTX secretion system is identical to that of V. cholerae. The function of these genes in pathogenesis was not analyzed, but the actin cross-linking domain was not found in MARTX sequences from Photorhabdus, which appear to have evolved unique cellular activities through the acquisition of a different genetic material.

Cadherin domain proteins

A particularly novel class of RTX proteins of Vibrio is represented by RtxL1 and RtxL2, which are characterized by the presence of more than one cadherin domain and were first identified in V. cholerae N16961. The rtxL1 and rtxL2 genes are arranged in tandem, which is different from the arrangement of the V. cholerae RTX gene cluster. RtxL1 and RtxL2 belong to the RTX family of hemolysin/leukotoxins, exhibiting hemolytic activity on human erythrocytes, but also appear to play a role in adherence and biofilm formation by V. cholerae N16961.

Both rtxL1 and rtxL2 genes are expressed in all V. cholerae isolates belonging to O1 (strains N16961, O395 and 569B), O139 (strain SG24) and non-O1-nonO139 (strains VCE232 and VCE309) serovars under in vitro conditions and appear to play a role in virulence in a mouse model.

Another member of the RTX-toxin group with cadherin domains was found as a novel RTX-like hemagglutinin (FrhA) of the V. cholerae O1 classical strain O395, the O1 El Tor strain A1552 and the O1 El Tor strain P27459. FrhA expression is positively regulated by the flagellar regulatory hierarchy. It mediates adherence to chitin and epithelial cells, enhances biofilm formation and is involved in intestinal colonization in infant mice.

RTX proteases

The RTX proteases belong to microbial zinc metalloproteases and form a group of approximately 50 kDa proteolytic enzymes secreted by a variety of pathogens. These proteases consist of an N-terminal proteolytic domain and a C-terminal calcium-binding RTX domain and are synthesized as zymogens that are activated by processing upon secretion.

The RTX proteases belong to the subgroup of metzincin metalloendopeptidases that contains an extended zinc-binding motif HEXXHXXGXXH, of which the three histidine residues are involved in binding the catalytically essential zinc ion, while the glutamic acid residue was postulated to take part in the catalytic activity. In addition, the metzincins all share a conserved methionine, which is located on a turn near the catalytic site, some 40–60 residues towards the C-terminus (the Met-turn).

To date, these proteases with characteristics of the RTX protein family were discovered and identified in six bacterial genera (Table 2): Serratia, Erwinia, Pseudomonas, Proteus, Caulobacter and Photorhabdus.

Genetic organization of RTX protease loci

The RTX protease locus of P. aeruginosa alkaline protease AprA was first identified by Duong in 1992. It consists of five ORFs, with aprD, aprE and aprF encoding the TISS proteins, the structural aprA gene for the protease and aprI encoding a protease inhibitor (inh).

The genetic organization of RTX protease operons varies. In Pseudomonas fluorescens CY091, the protease gene is located upstream of the inh and aprDEF transporter genes. The same organization of the locus was shown in P. luminescens, starting with the structural prtA gene for the protease, and followed by a gene encoding a putative protease inhibitor, inh and then the three members of an associated TISS, prtB, prtC and prtD (Fig. 4).

The genetic organization of RTX protease operons appears to depend on the number of secreted proteases. For example, E. chrysanthemi, a phytopathogenic enterobacterium, secretes four RTX proteases, where the first gene in the operon is the structural gene for prtG. This is followed by a gene encoding a putative protease inhibitor, inh, and then the three genes encoding TISS components, prtD, prtE and prtF. Structural genes for the other three RTX proteases prtB, prtC and prtA are adjacent to and belong to independent transcription units.

Unlike E. chrysanthemi, the other phytopathogenic species, Erwinia amylovora, secretes a single protease, while P. mirabilis produces two RTX proteases: ZapA and ZapE. ZapE shares homology with ZapA and other RTX proteases, but is larger (687 residues).

In some bacterial species, the RTX protease operon is combined with the genes for RTX lipases or other proteins. For example, in P. fluorescens B52, an aprX–lipA operon contains the protease (aprX) and the lipase (lipA) genes encoded at opposite ends of a contiguous set of genes. This also includes the protease inhibitor, TISS genes and two autotransporter genes (aprX-inh-aprDEF-prtAB-lipA), constituting an operon.

Structure–function relationships of RTX proteases

The typical size of RTX proteases is around 480 amino acid residues and 50 kDa, with the theoretical isoelectric point of most RTX proteases being about 4.0–4.6. first showed that the extracellular proteases B and C of E. chrysanthemi were synthesized as inactive zymogens proB and proC that were activated by autoprocessing of 16 or 18 amino acid residues (∼2 kDa) from the N-termini in the external medium containing divalent cations. As other zinc metalloproteases, the RTX proteases are inhibited by the general metalloprotease inhibitor EDTA, as well as by o-phenanthroline, a specific zinc metalloprotease inhibitor.

Three-dimensional structures of the alkaline proteases of P. aeruginosa (AprA) and PrtSM of S. marcescens were the first RTX protein structures resolved. Both proteases have a very similar two-domain structure. The N-terminal part is the proteolytic domain with a folding topology very similar to astacin, the archetypical metzincin protease. The C-terminal RTX domain consists of a 21-strand β sandwich. Within this domain, a ‘parallel β roll’ structure was first described, in which successive β strands are wound in a right-handed spiral and Ca2+ ions are bound within the turns between strands by a repeated GGXGXD sequence, thus setting a paradigm for the RTX portions of the whole protein family.

RTX protease inhibitors

The RTX protease inhibitor from E. chrysanthemi (Inh) was shown to be synthesized as a 12 kDa polypeptide having a signal peptide of 19 residues, which is cleaved off during Sec-dependent secretion into the periplasm. The mature 10 kDa inhibitor is entirely located in the periplasm of E. chrysanthemi and its presumed physiological role consists in protecting periplasmic proteins against proteases that might potentially leak out from the TISS channel assembly. Inh forms a 1: 1 complex with proteases A, B and C from E. chrysanthemi, AprA from P. aeruginosa and PrtSM from S. marcescens. In the crystal structure of the complex of S. marcescens PrtSM with Inh from E. chrysanthemi, the Inh was found to fold into a compact eight-stranded antiparallel β-barrel structure, interacting with the protease via five N-terminal residues that insert into the active site cleft of PrtSM.

Similar inhibitors have been characterized for other RTX proteases, such as P. aeruginosa, S. marcescens and Photorhabdus. The SmaPI inhibitor of S. marcescens, however, shows a very high protease specificity, while the protease inhibitor of P. aeruginosa (APRin) exhibits a significantly higher inhibitory activity (KD of 4 pM) compared with the inhibitors of E. chrysanthemi and S. marcescens (KD values from 1 to 10 μM).

Biological activity of RTX proteases

Pseudomonas aeruginosa AprA was shown to hydrolyze fibrin and fibrinogen, with specific activities similar to plasmin. AprA also exhibits an anticoagulant activity in human plasma, which was attributed to its direct fibrinogenolytic function. This may account, at least in part, for the most characteristic pathologic feature of the P. aeruginosa septicemia, which consists in hemorrhagic lesions lacking thrombi. Purified P. aeruginosa AprA also readily cleaves soluble laminin, which suggests its direct role (together with elastase) in both tissue invasion and hemorrhagic tissue necrosis in P. aeruginosa infections. Further, AprA also degrades human γ-interferon and inhibits its biological activity. Moreover, the effects of P. aeruginosa AprA on serum complement and on the isolated components C1q and C3 were also described. Because both C1q and physiological fragments of C3 (C3b, iC3b, and C3dg) are important opsonins, degradation of these molecules by Pseudomonas enzymes may facilitate the survival and proliferation of the organism in plasma.

The RTX protease from P. aeruginosa also appears to participate in liquefactive necrosis of the cornea through the digestion of the proteoglycan extracellular matrix, a major structural component of the cornea.

The ZapA protease, secreted by the urinary tract pathogen P. mirabilis, was found to cleave immunoglobulin G (IgG) and both IgA1 and IgA2, potentially conferring protection against opsonization of the bacterium during urinary tract infections.

The role of PrtA in the virulence of the bacterial entomopathogen Photorhabdus awaits clarification. The bacterium lives in symbiosis with nematodes that invade insects. Following entry into the insect, the bacteria are released from the nematode gut into the open blood system of the insect. Here, they secrete factors that kill the host and digest host tissues into nutrients for the replicating bacteria and nematodes. The secreted RTX protease PrtA of Photorhabdus, however, was not shown to be any major virulence factor and may play an alternative role in the host bioconversion.

Caulobacter crescentus synthesizes another unusual type of RTX protease called Sap (S-layer-associated protease). The N-terminal half of Sap exhibits significant similarity to other RTX proteases (e.g. AprA of P. aeruginosa), including the characteristic RTX repeat sequences, while the C-terminal half of Sap exhibits a significant similarity to the N-terminal region of the S-layer protein RsaA. The hypothesis is that Sap evolved by combining the catalytic portion of an RTX protease with an S-layer-like protein, perhaps to associate with nascent S-layer monomers to scan for modifications. Despite no clearly identifiable type I secretion signal, Sap still appears to be secreted by a TISS.

RTX bacterial lipases

Extracellular lipases of Gram-negative bacteria have been extensively characterized, being considered as valuable tools for a variety of biotechnological, biomedical and food industry applications. Until now, the genera Pseudomonas and Serratia were reported to produce RTX lipases of the I.3 subfamily. These do not have cysteine residues, do not require any additional gene products for activity and are secreted through TISS. Studies were conducted on lipases from P. fluorescens strain B52, SIK W1, no. 33, LS107d2, HU380, S. marcescens strains SM6, Sr41, Pseudomonas brassicacearum and Pseudomonas sp. strains MIS38 and KB700A. The polyester polyurethanases PueA and PueB of Pseudomonas chlororaphis are also classified as lipases.

Lipases from P. fluorescens show remarkable sequence similarity to that of S. marcescens, with an identity of about 65% over virtually the entire length of the sequence. The S. marcescens SM6 and Pseudomonas sp. MIS38 enzymes are 613 and 617 residues long, respectively, and compared with P. fluorescens lipase, which is 476 amino acids in length, appear to bear an extra domain consisting of 138 and 135 amino acid residues inserted between residues Asn405 and Thr406 of the P. fluorescens lipase backbone.

Lipase production by P. fluorescens B52 was shown to be repressed by iron and is regulated by temperature. Optimal lipase production occurs well below the optimal growth temperature. Lipase production is also regulated by the homologue of the E. coli EnvZ-OmpR two-component osmoregulatory system and its secretion is reduced by NaCl. The lipase production by P. brassicacearum was, in turn, shown to be under the control of phase variation.

In S. marcescens, the lipA gene is not linked to TISS component genes for LipB (ABC protein), LipC (MFP) and LipD (OMP), which, besides secreting LipA, can also promote the secretion of the metalloprotease, PrtA, and of the S-layer protein homologue SlaA. In P. fluorescens SIK W1, the RTX lipase gene tliA is situated downstream of the ABC exporter genes tliDEF, with genes prtA and inh, for an RTX protease and a protease inhibitor, being located upstream of tliDEF. In P. fluorescens strain no. 33, lipA is clustered with an aprA gene for an alkaline protease, aprDEF genes for the TISS and pspA and pspB genes for two homologues of Serratia serine proteases. In the P. fluorescens B52, lipA is situated downstream of the aprX-inh-aprDEF-prtAB operon. The organizations of the various gene clusters are depicted in Fig. 5.

RTX bacteriocins

Bacteriocins are structurally and functionally diverse bacterial toxins inhibiting the growth of other bacterial strains. Plasmid-borne genes for bacteriocins belonging to the RTX protein family (Table 3) were found in Gram-negative plant endosymbionts and pathogens, such as Rhizobium leguminosarum, Bradyrhizobium elkanii, Xylella fastidiosa, Xanthomonas oryzae or Agrobacterium tumefaciens, respectively. The mechanism of action of these putative bacterial toxins remains to be characterized. Nodulation competition experiments with mutants lacking the RTX bacteriocin activity indicated a role in the competitiveness of R. leguminosarum 248.

S-layer RTX proteins

S-layer proteins form regularly arranged two-dimensional crystalline arrays covering the entire outer surface of a broad spectrum of bacteria and archaea. These are often composed of a single protein or glycoprotein species of 40–200 kDa, which is endowed with the ability to assemble on the supporting envelope layer, thus representing one of the simplest self-assembly systems.

Several RTX proteins have been identified among S-layer proteins of pathogenic as well as nonpathogenic bacteria and cyanobacteria (see the section on RTX proteins involved in the motility of Cyanobacteria for more details). S-layer proteins have an acidic pH, lack cysteines and are produced in large quantities (10–12% of cell protein). They usually possess two structurally different domains, with the N-terminal part typically showing similarity to other S-layer proteins and the C-terminal part containing the characteristic RTX structures and an uncleaved TISS signal, respectively. The RTX repeats of S-layer proteins were shown to bind calcium, which was proposed to mediate proper S-layer crystallization.

The best-studied S-layer RTX protein is the 98 kDa RsaA that forms a hexagonal lattice on the cell surface of C. crescentus. Six copies of RsaA form a ring-like subunit that interconnects with other subunits to form a two-dimensional array consisting of approximately 40 000 RsaA units and with a porosity predicted to exclude molecules larger than ∼17 kDa. Some RsaA monomers are anchored to the outer bacterial membrane via interaction with smooth lipopolysaccharide, while the others are presumed to remain surface-associated by interaction with already attached RsaA monomers. Calcium appears to mediate proper RsaA crystallization and perturbations in RsaA at or near the RTX repeats result in the shedding of RsaA. It is presumed that a key function of the S-layer is to form a selective porosity barrier protecting the bacterium from a variety of predatorial assaults in the complex environments of bacterial biofilms. The S-layer appears to provide a barrier protecting against attack by the predatory Bdellovibrio-like bacterium.

The N-terminal part of the 98 kDa RsaA protein shows the highest homology score to Campylobacter fetus S-layer protein, while its C-terminal portion contains five RTX repeats. RsaA is produced constitutively to make up 10–12% of the total cell proteins, whereby it largely exceeds the secretion levels of any other type of RTX proteins. The ABC and MFP components of the TISS complex are encoded by rsaD and rsaE genes, located immediately downstream of the rsaA gene, while the rsaFa gene encodes one of two alternative OMP components of the RsaA secretion machinery and is located several kilobases downstream of the rsaA gene. The rsaFb gene encoding a second OMP component is completely unlinked. This is the only known example of a TISS that can utilize either of the two OMPs for the secretion of the same protein. Both OMPs, however, appear to be needed to handle the large amounts of RsaA produced, as neither one of the OMPs alone could induce wild-type secretion levels of RsaA.

Because of high secretion levels, cell surface location and geometrical packing of the RsaA protein, and thanks to the ease of genetic manipulation, the Caulobacter S-layer system has been exploited for biotechnology applications. These comprise the secretion of large quantities of ‘passenger’ proteins of economic and research interest into culture media, or surface presentation of heterologous protein inserts on the the S-layer, such as S-layer-mediated display of the IgG-binding domain of streptococcal protein G.

Three other S-layer RTX proteins, Crs (1361 residues), CsxA (1123 residues) and CsxB (1238 residues), have also been identified in Campylobacter rectus, a Gram-negative bacterium associated with several forms of human periodontal disease. These proteins appear to be the potential virulence factors involved in the evasion of host defense, such as phagocytic uptake and bactericidal activity of serum.

SlaA, another S-layer family RTX protein of 1002 residues partially similar to the C. crescentus RsaA protein, was found in S. marcescens. The 101 kDa protein appears to be exported by the Lip TISS system and a sequence dissimilarity in the N-terminal regions of SlaA has been observed among different strains of S. marcescens, which may be related to the antigenic variation of S. marcescens.

RTX proteins involved in the motility of Cyanobacteria

RTX proteins appear to be abundant in cyanobacteria, while the function of most of them remains elusive. Quite unexpectedly, however, some of the described cyanobacterial RTX proteins have been shown to be involved in cell motility, including SwmA of Synechococcus sp. strain WH8102, oscillin of Phormidium uncinatum or hemolysin-like protein Sll1951 of Synechocystis sp. strain PCC 6803.

The RTX protein SwmA was suggested to be part of the S-layer and to be required for the swimming motility of the marine unicellular cyanobacterium Synechococcus sp. strain WH8102. Swimming Synechococcus strains are observed to rotate around their longitudinal axis, as they translocate at speeds of up to 25 μm s−1 and once fortuitously attached to a microscope slide, they rotate around the point of attachment. Intriguingly, cells with an insertionally inactivated swmA gene lack the S-layer and are nonmotile, and yet still rotate around the point of attachment. Thus, SwmA is somehow required for the generation of thrust, but not torque. However, the mechanism by which the SwmA and the S-layer function in motility remains elusive.

SwmA is a 130 kDa polypeptide that appears to be glycosylated and contains glycine- and aspartate-rich repeats. It is assumed that RTX repeats of SwmA function in calcium ion bridging to the outer membrane and thereby mediate the anchoring of the S-layer. Treatment of Synechoccocus sp. strain WH8102 with the chelator EDTA, indeed, removes the outer membrane and solubilizes SwmA.

The surface fibrils on the top of P. uncinatum S-layer consist of a single rod-shaped RTX protein of 646 residues with 46 repeats, the oscillin. Its structure appears to favor gliding, a relatively slow and smooth surface-associated translocation. As proposed by Hoiczyk and colleagues, the highly glycosylated surface of oscillin fibrils possesses ideal physicochemical properties for the temporary adhesion of the slime necessary for the generation of thrust and the helical arrangement of oscillin fibrils might guide the rotation of the P. uncinatum filament.

The hemolysin-like RTX protein Sll1951 of 1741 residues produced by a unicellular freshwater cyanobacterium Synechocystis appears to be related to the elimination of motility, although the mechanism of its action remains largely unknown.

Nodulation RTX proteins

A 30 kDa RTX protein, NodO, was identified in R. leguminosarum bv. viciae and was shown to play a role in pea and vetch nodulation. The exact mechanism of the action of NodO in the process of the formation of nitrogen-fixing nodules on legume roots remains to be clarified. NodO was shown to form cation-selective channels in planar lipid bilayers, and two hypotheses were proposed on how this might enhance nodulation. One assumes that NodO pores in root cell membrane facilitate the passage of lipooligosaccharide nodulation factors. Another possibility could be the synergy of signalling resulting from cation fluxes through NodO channels across the plasma membrane, such as Ca2+ entry into root cells, thus amplifying the response induced by lipooligosaccharide nodulation factors. The pores formed by NodO in planar lipid bilayers are relatively large (>2 nm) and remain stably open for rather long, but are not voltage gated.

The prsDE genes for the TISS used by NodO appear to be conserved in all members of the Rhizobiaceae tested, even though these strains do not contain a nodO gene. The TISS, however, appears to be required for the secretion of several other Ca2+-binding proteins that are involved in the formation and the nitrogen-fixing capacity of nodules induced by R. leguminosarum bv. viciae. It also mediates the secretion of non-RTX glycanases PlyA and PlyB involved in the processing of Rhizobium exopolysaccharide.

RTX proteins of unknown biological function

Initially, two partially homologous proteins, FrpA and FrpC, possessing the characteristic carboxy-proximal repetitions of the RTX nonapeptide motif, were discovered in N. meningitidis, a commensal of the human nasopharynx that occasionally causes invasive meningococcal disease. Biological activity of the Frp (Fe-regulated protein) proteins remains unknown. However, their secretion under iron-limited growth conditions, which mimic the condition in body fluids, and the elevated titers of antibodies against Frp proteins found in convalescent sera of patients from meningococcal disease, suggest a potential role of the FrpC-like proteins in meningococcal carriage or virulence.

Meningococci appear to carry a whole polymorphic family of frpC-like genes that code for proteins sharing large portions of identical sequence and varying in the number of C-terminal RTX repeat blocks and/or in insertions/deletions in the N-terminal portions. For example, the 122 kDa FrpA harbors 13 copies of nonapeptide repeats, while the 198 kDa FrpC has 43 copies. The N-terminal 293 residues of FrpA and the 407 N-terminal residues of FrpC do not exhibit any sequence homology, apparently due to the foreign DNA inserted at the 5′-end of the frpA gene.

The prototype FrpC protein of N. meningitidis FAM20 or MC58 strains is an 1829-residue-long protein with an amino-terminal portion of 876 residues and a carboxy-terminal RTX moiety of 953 residues. The N-terminal portion of FrpC (residues 1–414) does not exhibit significant homology to any known proteins. However, it binds with very high affinity the FrpD lipoprotein, which is expressed from a gene located immediately upstream of the frpC gene in a predicted iron-regulated frpDC operon. Recently, a unique ‘clip-and-link’ self-processing module (SPM) located between residues 414 and 657 of FrpC was characterized. It exhibits a high degree of sequence homology to segments of several RTX proteins of unknown function that are encoded in genomes of plant and animal pathogens. Upon binding of calcium ions, the SPM produces a novel type of autocatalytic cleavage of the peptide bond between residues Asp414 and Pro415 of FrpC. Moreover, the newly generated N-terminal fragment of FrpC can be covalently linked to another protein molecule by a novel type of Asp-Lys isopeptide bond, which forms between the carboxyl group of the C-terminal Asp414 residue of the thus generated fragment and the ɛ-amino group of an internal lysine of another protein molecule. This defines a novel class of autoprocessing RTX proteins of unknown biological function, as the same type of calcium-dependent processing and cross-linking activity was also demonstrated for the purified ApxIVA protein of A. pleuropneumoniae.

ApxIVA is specific to the species of A. pleuropneumoniae and is genetically quite distant from other known RTX toxins. It is produced by A. pleuropneumoniae only during infections in vivo. When expressed as a recombinant protein in E. coli, it shows slight hemolytic activity and a distinct cohemolytic (CAMP) reaction. The apxIV determinant lacks the activator C gene and the type I secretion genes B and D, which are found in loci for the production of additional Apx toxins (ApxIA–ApxIIIA). However, upstream of apxIVA, an ORF can be found that is necessary for the hemolytic and CAMP activity of ApxIVA. ApxIVA was shown to be required for the full virulence of A. pleuropneumoniae, although its mechanism of action remains unclear.

Recently, a system for single-step affinity chromatography purification of untagged recombinant proteins based on the SPM of N. meningitidis was developed. The N-terminus of the SPM is fused to a target protein of interest and the C-terminus to an affinity tag. Upon loading of cell lysate and binding of the fusion protein to an affinity matrix, contaminating proteins are washed away and site-specific cleavage of the Asp-Pro bond linking the target protein to the self-excising module is induced by the addition of calcium ions. This results in the release of the target protein with only a single aspartic acid residue added at the C-terminus, while the self-excising affinity module remains trapped on the affinity matrix.

Identification of novel RTX proteins

Currently, almost 1000 prokaryotic genomes are fully sequenced and >2000 genome sequencing projects are in progress. We downloaded 840 fully sequenced bacterial genomes available in February 2009 and the putative RTX proteins were identified using three different methods: (1) pattern search; (2) Hidden Markov Model (HMM) search by hmmer 2.3.2; and (3) rps-blast.

For the identification of RTX proteins by pattern search, we tested the Prosite pattern PS00330 (DX[L/I]XXXXGXDX[L/I]XGGXXXD), the pattern proposed for the AC toxin GGXG(N/D)DX(L/I/F), and a universal short pattern for the calcium-binding site GGXGXD. Matches to a database of all bacterial proteins were identified by the program preg, which is a part of the emboss package. We analyzed >2.75 million sequences of a total length of 865 million amino acid residues. As expected, the longer the tested pattern was, the fewer the proteins that contained a positive hit. In total, 2598 hits to the Prosite pattern were found in 773 proteins. Shorter patterns were identified 5337 and 34 027 times, respectively, in 1210 and 20 963 proteins, respectively. To assess how many hits could be expected at random, we calculated an average amino acid composition of the bacterial protein database and generated a database of proteins of a random sequence, but with the same average composition. The average protein composition was calculated by pepstats and random sequences were generated by makeprotseq from the emboss package. The overall size of the randomized database was equal to the size of the database containing all bacterial proteins. The randomized database was tested for the presence of the aforementioned patterns and randomization and testing was repeated 100 times. On average, only 1.6 hits to the Prosite pattern were found in the random database. Not surprisingly, the other two shorter patterns were more frequent, with 373 and 20 504 hits on average for GGXG(N/D)DX(L/I/F) and GGXGXD motifs, respectively. The specificity of shorter patterns in identifying RTX proteins could be improved by searching for multiple hits in a single protein. For the purpose of this review, we only considered proteins containing a hit to the Prosite pattern as being a putative RTX protein.

The alternative approach to identification of calcium-binding sites common to RTX proteins was to use the HMM-based model for hemolysin-type calcium-binding repeats, the PF00353 from Pfam database release 23.0, which is an 18-residue-long model of two calcium-binding sites. We used hmmer 2.3.2 for the identification of proteins containing these calcium-binding sites. One thousand and thirteen proteins exhibited significant homology to the PF00353 Pfam model. On average, only 0.1 hits were found in the above-described random database. Thus, this approach appeared to be highly specific and generated virtually no false-positive hits.

The last used approach was to predict RTX proteins with rps-blast. We searched the bacterial protein database for homology to the 510-amino-acid-long COG2931, position-specific scoring matrix (PSSM) that represents RTX toxins and the related Ca2+-binding proteins. In contrast to Pfam models, there was no cutoff e-value defined for PSSM; therefore, we tested e-value cutoffs lower from 10, 1, 0.1 and 0.01. An e-value cutoff equal to or higher than 1 was not specific enough and >15 proteins were identified even in the random sequence database. Using an e-value of 0.1 as a cutoff, >400 proteins were identified in the bacterial database, compared with only 1.25 in the random sequence database. We therefore considered a cutoff of e-value equal to or <0.1 as being sufficiently stringent for the purpose of this review.

The combination of results from the three above-described methods revealed 1024 putative RTX proteins (Table S1) in 251 bacterial species. In bacterial genomes containing at least one putative RTX protein, components of the TISS were identified by hmmer. Towards this aim, the following models from the TIGRFAM database version 8.0 were used: (1) TIGR01842, TIGR01846 and TIGR03375 for ABC transporters (PrtD, HlyB and LssB-like); (2) TIGR01843 for MFP (HlyD-like); and (3) TIGR01844 for OMP (TolC-like) (Table S2).

Predicted RTX proteins

Bacteria harboring RTX protein genes were mostly Gammaproteobacteria (100 strains), Alphaproteobacteria (56 strains) and Betaproteobacteria (32 strains). Cyanobacteria were represented 25 times and RTX proteins appear, indeed, to be most abundant in cyanobacteria, with Trichodesmium erythraeum IMS101 bearing genes for 35 putative RTX proteins and up to 28 RTX proteins being encoded in the Acaryochloris marina MBIC11017 genome.

Surprisingly, putative RTX protein genes were also detected in seven Gram-positive bacteria genomes, with six Actinobacteria and one Firmicutes (Streptococcus sanguinis SK36), respectively. None of the Actinobacteria genomes, however, harbored any significant homologues of TISS components. Interestingly, the S. sanguinis SK36 genome contains an operon encoding an RTX protein, a HlyB-like protein and a HlyD-like protein. The TolC protein was not identified. A TolC homologue would, however, not be needed for Type I RTX secretion in a Gram-positive bacterium, which lacks the outer membrane. Whether the RTX protein and TISS components are really produced and functional in S. sanguinis remains to be determined.

RTX proteins identified by the aforementioned approaches vary significantly in length and range from <100 residues (protein NP_437763 of Sinorhizobium meliloti) to 36 800 residues (protein YP_378930 of Chlorobium chlorochromatii). Ninety percent of the putative RTX proteins fit to the range of 300–5000 residues, with an average of about 1600 residues. With the exception of three proteins, all RTX proteins appear to be acidic, with a theoretical pI in the range from 3.2 to 4.9 for 90% of the putative RTX proteins (Fig. 6).

We further predicted a number of possible Ca2+-binding sites in the identified RTX proteins. The following consensus sequences were considered as potential binding sites for Ca2+: (1) GGXGX(D/N), (2) GXXGND, (3) GDXGXD, (4) GDAXXN, (5) GXGGXD, (6) GEAGDD and (7) GAGRVD, respectively. The highest number of almost 200 and 170 calcium-binding sites was predicted for the putative 4334-residue-long RTX protein of Chlorobium limicola and the 5107-residue-long protein from Pseudomonas syringae pv. phaseolicola, respectively.

Independent of the primary annotation, the prediction of functions of the putative RTX proteins was attempted. We used rps-blast ver 2.2.20 to detect significant homologies of putative RTX proteins to PSSMs in the CDD database version 2.16, which contains almost 32 000 domain models from Pfam, COG, SMART and KOG databases. Based on detected homologies to the CDD database, we were able to assign putative functions to about 30% of the identified RTX proteins (Table S1). The largest group would consist of proteases (112) and adhesins (113), the latter falling into two major classes of cadherins (52) and vWA domain proteins, respectively (46). A further 20 lipases and 16 peroxidases were predicted.

About 20 enzymes were predicted to be involved in the degradation of saccharides and polysaccharides as glycosyl hydrolases, polysaccharide hydrolases and endoglucanases. About 20 putative RTX proteins might be involved in the degradation of DNA as endonucleases, nucleotidases and phosphodiesterases. A further four might act as phytases, one as a sulfatase, three as cyclophilin-like peptidylprolyl cis–trans isomerases and five as phosphatases, respectively.

Interestingly, three β-lactamases and one putative lysozyme were also predicted among the computationally detected putative RTX proteins. A further nine putative RTX proteins appear to exhibit weak homology to Hedgehog/Intein domain proteins, suggesting that they might undergo autoprocessing and splicing.

Conclusions

Being first recognized as a group of pore-forming bacterial leukotoxins two decades ago, the RTX family nowadays comprises a particularly broad range of exoproteins that play important roles in the colonization of various habitats and hosts by Gram-negative bacteria (Fig. 7). Bioinformatic mining of the growing database of bacterial genomes indicates that a large spectrum of biological and biochemical activities of RTX proteins still remains to be characterized. The unique and central overarching feature of RTX proteins is the presence of variable numbers of the calcium-binding glycine- and aspartate-rich C-terminal repeats. These separate the unprocessed C-terminal secretion signals from the specific bodies of individual proteins. By being intrinsically unstructured at the very low calcium concentrations found within bacterial cytoplasm, the repeats maintain an unfolded or a loosely folded state of the RTX protein that enables recognition of its secretion signal by a dedicated type I secretion ATPase assembly. This function of RTX repeats allows a single-step passage of extremely large proteins through the entire Gram-negative cell envelope. Binding of extracellular calcium ions to repeats emerging at the bacterial surface then ‘turns on’ structuration of the repeats, pulling the protein out of the cells and driving folding of the rest of the protein. Moreover, the RTX repeats themselves support an amazingly vast array of biological activities, be it a role in the formation of S-layers, bacterial adherence/motility or host–receptor interaction and membrane penetration of RTX proteins. Hence, through a simple variation of number and block arrangement of a small repeat unit, an elegant construction of sophisticated biological functions is achieved.

References 405

  1. 1.

    Adusu TE, Conlon PD, Shewen PE, Black WD. Pasteurella haemolytica leukotoxin induces histamine release from bovine pulmonary mast cells. Can J Vet Res. 1994;58:1-5.

    Not in our library

  2. 2.

    Ahn JH, Pan JG, Rhee JS. Identification of the tliDEF ABC transporter specific for lipase in Pseudomonas fluorescens SIK W1. J Bacteriol. 1999;181:1847-1852.

    Not in our library10.1128/jb.181.6.1847-1852.1999

  3. 3.

    Akatsuka H, Kawai E, Omori K, Komatsubara S, Shibatani T, Tosa T. The lipA gene of Serratia marcescens which encodes an extracellular lipase having no N-terminal signal peptide. J Bacteriol. 1994;176:1949-1956.

    Not in our library10.1128/jb.176.7.1949-1956.1994

  4. 4.

    Akatsuka H, Kawai E, Omori K, Shibatani T. The three genes lipB, lipC, and lipD involved in the extracellular secretion of the Serratia marcescens lipase which lacks an N-terminal signal peptide. J Bacteriol. 1995;177:6381-6389.

    Not in our library10.1128/jb.177.22.6381-6389.1995

  5. 5.

    Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389-3402.

    Not in our library10.1093/nar/25.17.3389

  6. 6.

    Amada K, Haruki M, Imanaka T, Morikawa M, Kanaya S. Overproduction in Escherichia coli, purification and characterization of a family I.3 lipase from Pseudomonas sp. MIS38. Biochim Biophys Acta. 2000;1478:201-210.

    Not in our library10.1016/s0167-4838(00)00046-7

  7. 7.

    Ambagala TC, Ambagala AP, Srikumaran S. The leukotoxin of Pasteurella haemolytica binds to beta(2) integrins on bovine leukocytes. FEMS Microbiol Lett. 1999;179:161-167.

    Not in our library10.1111/j.1574-6968.1999.tb08722.x

  8. 8.

    Andersen C, Hughes C, Koronakis V. Protein export and drug efflux through bacterial channel–tunnels. Curr Opin Cell Biol. 2001;13:412-416.

    Not in our library10.1016/s0955-0674(00)00229-5

  9. 9.

    Angelos JA, Hess JF, George LW. An RTX operon in hemolytic Moraxella bovis is absent from nonhemolytic strains. Vet Microbiol. 2003;92:363-377.

    Not in our library10.1016/s0378-1135(02)00410-8

  10. 10.

    Aono R, Tsukagoshi N, Yamamoto M. Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12. J Bacteriol. 1998;180:938-944.

    Not in our library10.1128/jb.180.4.938-944.1998

  11. 11.

    Atapattu DN, Czuprynski CJ. Mannheimia haemolytica leukotoxin induces apoptosis of bovine lymphoblastoid cells (BL-3) via a caspase-9-dependent mitochondrial pathway. Infect Immun. 2005;73:5504-5513.

    Not in our library10.1128/iai.73.9.5504-5513.2005

  12. 12.

    Awram P, Smit J. The Caulobacter crescentus paracrystalline S-layer protein is secreted by an ABC transporter (type I) secretion apparatus. J Bacteriol. 1998;180:3062-3069.

    Not in our library10.1128/jb.180.12.3062-3069.1998

  13. 13.

    Awram P, Smit J. Identification of lipopolysaccharide O antigen synthesis genes required for attachment of the S-layer of Caulobacter crescentus. Microbiology. 2001;147:1451-1460.

    Not in our library10.1099/00221287-147-6-1451

  14. 14.

    Bachelet M, Richard MJ, Francois D, Polla BS. Mitochondrial alterations precede Bordetella pertussis-induced apoptosis. FEMS Immunol Med Mic. 2002;32:125-131.

    Not in our library10.1111/j.1574-695x.2002.tb00544.x

  15. 15.

    Bakas L, Ostolaza H, Vaz WL, Goni FM. Reversible adsorption and nonreversible insertion of Escherichia coli alpha-hemolysin into lipid bilayers. Biophys J. 1996;71:1869-1876.

    Not in our library10.1016/s0006-3495(96)79386-4

  16. 16.

    Balashova NV, Diaz R, Balashov SV, Crosby JA, Kachlany SC. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron. J Bacteriol. 2006;188:8658-8661.

    Not in our library10.1128/jb.01253-06

  17. 17.

    Balashova NV, Park DH, Patel JK, Figurski DH, Kachlany SC. Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans. Infect Immun. 2007;75:4490-4497.

    Not in our library10.1128/iai.00288-07

  18. 18.

    Balashova NV, Shah C, Patel JK, Megalla S, Kachlany SC. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells. Gene. 2009;443:42-47.

    Not in our library10.1016/j.gene.2009.05.002

  19. 19.

    Barry EM, Weiss AA, Ehrmann IE, Gray MC, Hewlett EL, Goodwin MS. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J Bacteriol. 1991;173:720-726.

    Not in our library10.1128/jb.173.2.720-726.1991

  20. 20.

    Basar T, Havlicek V, Bezouskova S, Halada P, Hackett M, Sebo P. The conserved lysine 860 in the additional fatty-acylation site of Bordetella pertussis adenylate cyclase is crucial for toxin function independently of its acylation status. J Biol Chem. 1999;274:10777-10783.

    Not in our library10.1074/jbc.274.16.10777

  21. 21.

    Basar T, Havlicek V, Bezouskova S, Hackett M, Sebo P. Acylation of lysine 983 is sufficient for toxin activity of Bordetella pertussis adenylate cyclase. Substitutions of alanine 140 modulate acylation site selectivity of the toxin acyltransferase CyaC. J Biol Chem. 2001;276:348-354.

    Not in our library10.1074/jbc.m006463200

  22. 22.

    Basler M, Masin J, Osicka R, Sebo P. Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes. Infect Immun. 2006;74:2207-2214.

    Not in our library10.1128/iai.74.4.2207-2214.2006

  23. 23.

    Basler M, Knapp O, Masin J, et al. Segments crucial for membrane translocation and pore-forming activity of Bordetella adenylate cyclase toxin. J Biol Chem. 2007;282:12419-12429.

    Not in our library10.1074/jbc.m611226200

  24. 24.

    Bassinet L, Fitting C, Housset B, Cavaillon JM, Guiso N. Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells. Infect Immun. 2004;72:5530-5533.

    Not in our library10.1128/iai.72.9.5530-5533.2004

  25. 25.

    Bauche C, Chenal A, Knapp O, Bodenreider C, Benz R, Chaffotte A, Ladant D. Structural and functional characterization of an essential RTX subdomain of Bordetella pertussis adenylate cyclase toxin. J Biol Chem. 2006;281:16914-16926.

    Not in our library10.1074/jbc.m601594200

  26. 26.

    Bauer ME, Welch RA. Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Infect Immun. 1996a;64:167-175.

    Not in our library10.1128/iai.64.1.167-175.1996

  27. 27.

    Bauer ME, Welch RA. Association of RTX toxins with erythrocytes. Infect Immun. 1996b;64:4665-4672.

    Not in our library10.1128/iai.64.11.4665-4672.1996

  28. 28.

    Baumann U. Crystal structure of the 50 kDa metallo protease from Serratia marcescens. J Mol Biol. 1994;242:244-251.

    Not in our library10.1006/jmbi.1994.1576

  29. 29.

    Baumann U, Wu S, Flaherty KM, McKay DB. Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J. 1993;12:3357-3364.

    Not in our library10.1002/j.1460-2075.1993.tb06009.x

  30. 30.

    Baumann U, Bauer M, Letoffe S, Delepelaire P, Wandersman C. Crystal structure of a complex between Serratia marcescens metallo-protease and an inhibitor from Erwinia chrysanthemi. J Mol Biol. 1995;248:653-661.

    Not in our library10.1006/jmbi.1995.0249

  31. 31.

    Beard MK, Moore LJ. Reproduction of bovine keratoconjunctivitis with a purified haemolytic and cytotoxic fraction of Moraxella bovis. Vet Microbiol. 1994;42:15-33.

    Not in our library10.1016/0378-1135(94)90074-4

  32. 32.

    Bejerano M, Nisan I, Ludwig A, Goebel W, Hanski E. Characterization of the C-terminal domain essential for toxic activity of adenylate cyclase toxin. Mol Microbiol. 1999;31:381-392.

    Not in our library10.1046/j.1365-2958.1999.01183.x

  33. 33.

    Bellalou J, Sakamoto H, Ladant D, Geoffroy C, Ullmann A. Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect Immun. 1990;58:3242-3247.

    Not in our library10.1128/iai.58.10.3242-3247.1990

  34. 34.

    Benz R, Schmid A, Wagner W, Goebel W. Pore formation by the Escherichia coli hemolysin: evidence for an association–dissociation equilibrium of the pore-forming aggregates. Infect Immun. 1989;57:887-895.

    Not in our library10.1128/iai.57.3.887-895.1989

  35. 35.

    Benz R, Maier E, Ladant D, Ullmann A, Sebo P. Adenylate cyclase toxin (CyaA) of Bordetella pertussis. Evidence for the formation of small ion-permeable channels and comparison with HlyA of Escherichia coli. J Biol Chem. 1994;269:27231-27239.

    Not in our library

  36. 36.

    Berridge MJ, Bootman MD, Lipp P. Calcium – a life and death signal. Nature. 1998;395:645-648.

    Not in our library10.1038/27094

  37. 37.

    Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Bio. 2000;1:11-21.

    Not in our library10.1038/35036035

  38. 38.

    Berthold P, Forti D, Kieba IR, Rosenbloom J, Taichman NS, Lally ET. Electron immunocytochemical localization of Actinobacillus actinomycetemcomitans leukotoxin. Oral Microbiol Immun. 1992;7:24-27.

    Not in our library10.1111/j.1399-302x.1992.tb00015.x

  39. 39.

    Berthoud H, Frey J, Kuhnert P. Characterization of Aqx and its operon: the hemolytic RTX determinant of Actinobacillus equuli. Vet Microbiol. 2002;87:159-174.

    Not in our library10.1016/s0378-1135(02)00048-2

  40. 40.

    Betsou F, Sebo P, Guiso N. CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun. 1993;61:3583-3589.

    Not in our library10.1128/iai.61.9.3583-3589.1993

  41. 41.

    Beveridge TJ, Pouwels PH, Sara M, et al. Functions of S-layers. FEMS Microbiol Rev. 1997;20:99-149.

    Not in our library10.1111/j.1574-6976.1997.tb00305.x

  42. 42.

    Bhakdi S, Mackman N, Nicaud JM, Holland IB. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect Immun. 1986;52:63-69.

    Not in our library10.1128/iai.52.1.63-69.1986

  43. 43.

    Bhakdi S, Greulich S, Muhly M, Eberspacher B, Becker H, Thiele A, Hugo F. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med. 1989;169:737-754.

    Not in our library10.1084/jem.169.3.737

  44. 44.

    Bhakdi S, Muhly M, Korom S, Schmidt G. Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J Clin Invest. 1990;85:1746-1753.

    Not in our library10.1172/jci114631

  45. 45.

    Bingle WH, Nomellini JF, Smit J. Linker mutagenesis of the Caulobacter crescentus S-layer protein: toward a definition of an N-terminal anchoring region and a C-terminal secretion signal and the potential for heterologous protein secretion. J Bacteriol. 1997a;179:601-611.

    Not in our library10.1128/jb.179.3.601-611.1997

  46. 46.

    Bingle WH, Nomellini JF, Smit J. Cell-surface display of a Pseudomonas aeruginosa strain K pilin peptide within the paracrystalline S-layer of Caulobacter crescentus. Mol Microbiol. 1997b;26:277-288.

    Not in our library10.1046/j.1365-2958.1997.5711932.x

  47. 47.

    Bingle WH, Nomellini JF, Smit J. Secretion of the Caulobacter crescentus S-layer protein: further localization of the C-terminal secretion signal and its use for secretion of recombinant proteins. J Bacteriol. 2000;182:3298-3301.

    Not in our library10.1128/jb.182.11.3298-3301.2000

  48. 48.

    Boardman BK, Satchell KJ. Vibrio cholerae strains with mutations in an atypical type I secretion system accumulate RTX toxin intracellularly. J Bacteriol. 2004;186:8137-8143.

    Not in our library10.1128/jb.186.23.8137-8143.2004

  49. 49.

    Boardman BK, Meehan BM, Fullner Satchell KJ. Growth phase regulation of Vibrio cholerae RTX toxin export. J Bacteriol. 2007;189:1827-1835.

    Not in our library10.1128/jb.01766-06

  50. 50.

    Bode W, Grams F, Reinemer P, Gomis-Ruth FX, Baumann U, McKay DB, Stocker W. The metzincin-superfamily of zinc-peptidases. Adv Exp Med Biol. 1996;389:1-11.

    Not in our library10.1007/978-1-4613-0335-0_1

  51. 51.

    Bowen DJ, Rocheleau TA, Grutzmacher CK, et al. Genetic and biochemical characterization of PrtA, an RTX-like metalloprotease from Photorhabdus. Microbiology. 2003;149:1581-1591.

    Not in our library10.1099/mic.0.26171-0

  52. 52.

    Brahamsha B. An abundant cell-surface polypeptide is required for swimming by the nonflagellated marine cyanobacterium Synechococcus. P Natl Acad Sci USA. 1996;93:6504-6509.

    Not in our library10.1073/pnas.93.13.6504

  53. 53.

    Braun M, Kuhnert P, Nicolet J, Burnens AP, Frey J. Cloning and characterization of two bistructural S-layer-RTX proteins from Campylobacter rectus. J Bacteriol. 1999;181:2501-2506.

    Not in our library10.1128/jb.181.8.2501-2506.1999

  54. 54.

    Brown JF, Leite F, Czuprynski CJ. Binding of Pasteurella haemolytica leukotoxin to bovine leukocytes. Infect Immun. 1997;65:3719-3724.

    Not in our library10.1128/iai.65.9.3719-3724.1997

  55. 55.

    Brown MH, Brightman AH, Fenwick BW, Rider MA. Infectious bovine keratoconjunctivitis: a review. J Vet Intern Med. 1998;12:259-266.

    Not in our library10.1111/j.1939-1676.1998.tb02120.x

  56. 56.

    Bumba L, Masin J, Fiser R, Sebo P. Bordetella adenylate cyclase toxin mobilizes its b2 integrin receptor into lipid rafts to accomplish translocation across target cell membrane in two steps. PLoS Pathog. 2010;6:e1000901.

    Not in our library10.1371/journal.ppat.1000901

  57. 57.

    Burrows LL, Lo RY. Molecular characterization of an RTX toxin determinant from Actinobacillus suis. Infect Immun. 1992;60:2166-2173.

    Not in our library10.1128/iai.60.6.2166-2173.1992

  58. 58.

    Cavalieri SJ, Snyder IS. Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro. Infect Immun. 1982;37:966-974.

    Not in our library10.1128/iai.37.3.966-974.1982

  59. 59.

    Chabeaud P, de Groot A, Bitter W, Tommassen J, Heulin T, Achouak W. Phase-variable expression of an operon encoding extracellular alkaline protease, a serine protease homolog, and lipase in Pseudomonas brassicacearum. J Bacteriol. 2001;183:2117-2120.

    Not in our library10.1128/jb.183.6.2117-2120.2001

  60. 60.

    Chang YF, Young R, Post D, Struck DK. Identification and characterization of the Pasteurella haemolytica leukotoxin. Infect Immun. 1987;55:2348-2354.

    Not in our library10.1128/iai.55.10.2348-2354.1987

  61. 61.

    Chang YF, Young R, Struck DK. Cloning and characterization of a hemolysin gene from Actinobacillus (Haemophilus) pleuropneumoniae. DNA. 1989;8:635-647.

    Not in our library10.1089/dna.1.1989.8.635

  62. 62.

    Chang YF, Ma DP, Young R, Struck DK. Cloning, sequencing and expression of a Pasteurella haemolytica A1 gene encoding a PurK-like protein. DNA Sequence. 1993;3:357-367.

    Not in our library10.3109/10425179309020837

  63. 63.

    Chatterjee R, Nag S, Chaudhuri K. Identification of a new RTX-like gene cluster in Vibrio cholerae. FEMS Microbiol Lett. 2008;284:165-171.

    Not in our library10.1111/j.1574-6968.2008.01199.x

  64. 64.

    Chen CY, Wu KM, Chang YC, et al. Comparative genome analysis of Vibrio vulnificus, a marine pathogen. Genome Res. 2003;13:2577-2587.

    Not in our library10.1101/gr.1295503

  65. 65.

    Cheong TG, Chan M, Kurunathan S, et al. Construction and characterization of rtxA and rtxC mutants of auxotrophic O139 Vibrio cholerae. Microb Pathogenesis. 2010;48:85-90.

    Not in our library10.1016/j.micpath.2009.11.001

  66. 66.

    Cherif A, Rezgui W, Raddadi N, Daffonchio D, Boudabous A. Characterization and partial purification of entomocin 110, a newly identified bacteriocin from Bacillus thuringiensis subsp. Entomocidus HD110. Microbiol Res. 2006;163:684-692.

    Not in our library10.1016/j.micres.2006.10.005

  67. 67.

    Cheryk LA, Hooper-McGrevy KE, Gentry PA. Alterations in bovine platelet function and acute phase proteins induced by Pasteurella haemolytica A1. Can J Vet Res. 1998;62:1-8.

    Not in our library

  68. 68.

    Chow KH, Ng TK, Yuen KY, Yam WC. Detection of RTX toxin gene in Vibrio cholerae by PCR. J Clin Microbiol. 2001;39:2594-2597.

    Not in our library10.1128/jcm.39.7.2594-2597.2001

  69. 69.

    Christie R, Atkins NE, Munch-Petersen E. A note on a lytic phenomenon shown by group B streptococci. Aust J Exp Biol Med. 1944;22:197-200.

    Not in our library10.1038/icb.1945.30

  70. 70.

    Chung GH, Lee YP, Jeohn GH, Yoo OJ, Rhee JS. Cloning and nucleotide sequence of thermostable lipase gene from Pseudomonas fluorescens SIK W1. Agr Biol Chem. 1991;55:2359-2365.

    Not in our library

  71. 71.

    Clinkenbeard KD, Upton ML. Lysis of bovine platelets by Pasteurella haemolytica leukotoxin. Am J Vet Res. 1991;52:453-457.

    Not in our library

  72. 72.

    Clinkenbeard KD, Mosier DA, Confer AW. Effects of Pasteurella haemolytica leukotoxin on isolated bovine neutrophils. Toxicon. 1989a;27:797-804.

    Not in our library10.1016/0041-0101(89)90047-0

  73. 73.

    Clinkenbeard KD, Mosier DA, Timko AL, Confer AW. Effects of Pasteurella haemolytica leukotoxin on cultured bovine lymphoma cells. Am J Vet Res. 1989b;50:271-275.

    Not in our library

  74. 74.

    Confer DL, Eaton JW. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science. 1982;217:948-950.

    Not in our library10.1126/science.6287574

  75. 75.

    Coote JG. Structural and functional relationships among the RTX toxin determinants of gram-negative bacteria. FEMS Microbiol Rev. 1992;8:137-161.

    Not in our library10.1111/j.1574-6968.1992.tb04961.x

  76. 76.

    Cordero CL, Kudryashov DS, Reisler E, Satchell KJ. The actin cross-linking domain of the Vibrio cholerae RTX toxin directly catalyzes the covalent cross-linking of actin. J Biol Chem. 2006;281:32366-32374.

    Not in our library10.1074/jbc.m605275200

  77. 77.

    Cortajarena AL, Goni FM, Ostolaza H. Glycophorin as a receptor for Escherichia coli alpha-hemolysin in erythrocytes. J Biol Chem. 2001;276:12513-12519.

    Not in our library10.1074/jbc.m006792200

  78. 78.

    Cortajarena AL, Goni FM, Ostolaza H. A receptor-binding region in Escherichia coli alpha-haemolysin. J Biol Chem. 2003;278:19159-19163.

    Not in our library10.1074/jbc.m208552200

  79. 79.

    Crosby JA, Kachlany SC. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans. Gene. 2007;388:83-92.

    Not in our library10.1016/j.gene.2006.10.004

  80. 80.

    Cruz WT, Young R, Chang YF, Struck DK. Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin. Mol Microbiol. 1990;4:1933-1939.

    Not in our library10.1111/j.1365-2958.1990.tb02042.x

  81. 81.

    Cudd L, Clarke C, Clinkenbeard K. Contribution of intracellular calcium stores to an increase in cytosolic calcium concentration induced by Mannheimia haemolytica leukotoxin. FEMS Microbiol Lett. 2003a;225:23-27.

    Not in our library10.1016/s0378-1097(03)00471-3

  82. 82.

    Cudd L, Clarke C, Clinkenbeard K. Mannheimia haemolytica leukotoxin-induced increase in leukotriene B4 production by bovine neutrophils is mediated by a sustained and excessive increase in intracellular calcium concentration. FEMS Microbiol Lett. 2003b;224:85-90.

    Not in our library10.1016/s0378-1097(03)00432-4

  83. 83.

    Czuprynski CJ, Welch RA. Biological effects of RTX toxins: the possible role of lipopolysaccharide. Trends Microbiol. 1995;3:480-483.

    Not in our library10.1016/s0966-842x(00)89016-2

  84. 84.

    Czuprynski CJ, Noel EJ, Ortiz-Carranza O, Srikumaran S. Activation of bovine neutrophils by partially purified Pasteurella haemolytica leukotoxin. Infect Immun. 1991;59:3126-3133.

    Not in our library10.1128/iai.59.9.3126-3133.1991

  85. 85.

    Dadaglio G, Moukrim Z, Lo-Man R, Sheshko V, Sebo P, Leclerc C. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis. Infect Immun. 2000;68:3867-3872.

    Not in our library10.1128/iai.68.7.3867-3872.2000

  86. 86.

    Dahler GS, Barras F, Keen NT. Cloning of genes encoding extracellular metalloproteases from Erwinia chrysanthemi EC16. J Bacteriol. 1990;172:5803-5815.

    Not in our library10.1128/jb.172.10.5803-5815.1990

  87. 87.

    Dassanayake RP, Maheswaran SK, Srikumaran S. Monomeric expression of bovine beta2-integrin subunits reveals their role in Mannheimia haemolytica leukotoxin-induced biological effects. Infect Immun. 2007;75:5004-5010.

    Not in our library10.1128/iai.00808-07

  88. 88.

    Delepelaire P. Type I secretion in gram-negative bacteria. Biochim Biophys Acta. 2004;1694:149-161.

    Not in our library10.1016/j.bbamcr.2004.05.001

  89. 89.

    Delepelaire P, Wandersman C. Protease secretion by Erwinia chrysanthemi. Proteases B and C are synthesized and secreted as zymogens without a signal peptide. J Biol Chem. 1989;264:9083-9089.

    Not in our library

  90. 90.

    Delepelaire P, Wandersman C. The SecB chaperone is involved in the secretion of the Serratia marcescens HasA protein through an ABC transporter. EMBO J. 1998;17:936-944.

    Not in our library10.1093/emboj/17.4.936

  91. 91.

    Demuth DR, James D, Kowashi Y, Kato S. Interaction of Actinobacillus actinomycetemcomitans outer membrane vesicles with HL60 cells does not require leukotoxin. Cell Microbiol. 2003;5:111-121.

    Not in our library10.1046/j.1462-5822.2003.00259.x

  92. 92.

    Deshpande MS, Ambagala TC, Ambagala AP, Kehrli ME, Srikumaran S. Bovine CD18 is necessary and sufficient to mediate Mannheimia (Pasteurella) haemolytica leukotoxin-induced cytolysis. Infect Immun. 2002;70:5058-5064.

    Not in our library10.1128/iai.70.9.5058-5068.2002

  93. 93.

    Diaz R, Ghofaily LA, Patel J, Balashova NV, Freitas AC, Labib I, Kachlany SC. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans. Microb Pathogenesis. 2006;40:48-55.

    Not in our library10.1016/j.micpath.2005.10.005

  94. 94.

    Dileepan T, Thumbikat P, Walcheck B, Kannan MS, Maheswaran SK. Recombinant expression of bovine LFA-1 and characterization of its role as a receptor for Mannheimia haemolytica leukotoxin. Microb Pathogenesis. 2005;38:249-257.

    Not in our library10.1016/j.micpath.2005.02.005

  95. 95.

    Dileepan T, Kachlany SC, Balashova NV, Patel J, Maheswaran SK. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin. Infect Immun. 2007a;75:4851-4856.

    Not in our library10.1128/iai.00314-07

  96. 96.

    Dileepan T, Kannan MS, Walcheck B, Maheswaran SK. Integrin-EGF-3 domain of bovine CD18 is critical for Mannheimia haemolytica leukotoxin species-specific susceptibility. FEMS Microbiol Lett. 2007b;274:67-72.

    Not in our library10.1111/j.1574-6968.2007.00818.x

  97. 97.

    Duchaud E, Rusniok C, Frangeul L, et al. The genome sequence of the entomopathogenic bacterium Photorhabdus luminescens. Nat Biotechnol. 2003;21:1307-1313.

    Not in our library10.1038/nbt886

  98. 98.

    Duong F, Lazdunski A, Cami B, Murgier M. Sequence of a cluster of genes controlling synthesis and secretion of alkaline protease in Pseudomonas aeruginosa: relationships to other secretory pathways. Gene. 1992;121:47-54.

    Not in our library10.1016/0378-1119(92)90160-q

  99. 99.

    Duong F, Soscia C, Lazdunski A, Murgier M. The Pseudomonas fluorescens lipase has a C-terminal secretion signal and is secreted by a three-component bacterial ABC-exporter system. Mol Microbiol. 1994;11:1117-1126.

    Not in our library10.1111/j.1365-2958.1994.tb00388.x

  100. 100.

    Eberspächer B, Hugo F, Bhakdi S. Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin. Infect Immun. 1989;57:983-988.

    Not in our library10.1128/iai.57.3.983-988.1989

  101. 101.

    Eberspächer B, Hugo F, Pohl M, Bhakdi S. Functional similarity between the haemolysins of Escherichia coli and Morganella morganii. J Med Microbiol. 1990;33:165-170.

    Not in our library10.1099/00222615-33-3-165

  102. 102.

    Economou A, Hamilton WD, Johnston AW, Downie JA. The Rhizobium nodulation gene nodO encodes a Ca2(+)-binding protein that is exported without N-terminal cleavage and is homologous to haemolysin and related proteins. EMBO J. 1990;9:349-354.

    Not in our library10.1002/j.1460-2075.1990.tb08117.x

  103. 103.

    Eddy SR. Profile hidden Markov models. Bioinformatics. 1998;14:755-763.

    Not in our library10.1093/bioinformatics/14.9.755

  104. 104.

    El-Azami-El-Idrissi M, Bauche C, Loucka J, Osicka R, Sebo P, Ladant D, Leclerc C. Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: role of toxin acylation and identification of the main integrin interaction domain. J Biol Chem. 2003;278:38514-38521.

    Not in our library10.1074/jbc.m304387200

  105. 105.

    Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. J Immunol. 1996;156:4697-4706.

    Not in our library

  106. 106.

    Fayolle C, Ladant D, Karimova G, Ullmann A, Leclerc C. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope. J Immunol. 1999;162:4157-4162.

    Not in our library

  107. 107.

    Fayolle C, Osickova A, Osicka R, et al. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity. J Virol. 2001;75:7330-7338.

    Not in our library10.1128/jvi.75.16.7330-7338.2001

  108. 108.

    Felmlee T, Welch RA. Alterations of amino acid repeats in the Escherichia coli hemolysin affect cytolytic activity and secretion. P Natl Acad Sci USA. 1988;85:5269-5273.

    Not in our library10.1073/pnas.85.14.5269

  109. 109.

    Felmlee T, Pellett S, Welch RA. Nucleotide sequence of an Escherichia coli chromosomal hemolysin. J Bacteriol. 1985;163:94-105.

    Not in our library10.1128/jb.163.1.94-105.1985

  110. 110.

    Feltzer RE, Gray RD, Dean WL, Pierce WM. Alkaline proteinase inhibitor of Pseudomonas aeruginosa. Interaction of native and N-terminally truncated inhibitor proteins with Pseudomonas metalloproteinases. J Biol Chem. 2000;275:21002-21009.

    Not in our library10.1074/jbc.m002088200

  111. 111.

    Fetzer AE, Werner AS, Hagstrom JW. Pathologic features of pseudomonal pneumonia. Am Rev Respir Dis. 1967;96:1121-1130.

    Not in our library10.1164/arrd.1967.96.6.1121

  112. 112.

    Fine DH, Kaplan JB, Kachlany SC, Schreiner HC. How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontol 2000. 2006;42:114-157.

    Not in our library10.1111/j.1600-0757.2006.00189.x

  113. 113.

    Finn RD, Mistry J, Schuster-Bockler B, et al. Pfam: clans, web tools and services. Nucleic Acids Res. 2006;34:D247-D251.

    Not in our library10.1093/nar/gkj149

  114. 114.

    Finnie C, Hartley NM, Findlay KC, Downie JA. The Rhizobium leguminosarum prsDE genes are required for secretion of several proteins, some of which influence nodulation, symbiotic nitrogen fixation and exopolysaccharide modification. Mol Microbiol. 1997;25:135-146.

    Not in our library10.1046/j.1365-2958.1997.4471803.x

  115. 115.

    Finnie C, Zorreguieta A, Hartley NM, Downie JA. Characterization of Rhizobium leguminosarum exopolysaccharide glycanases that are secreted via a type I exporter and have a novel heptapeptide repeat motif. J Bacteriol. 1998;180:1691-1699.

    Not in our library10.1128/jb.180.7.1691-1699.1998

  116. 116.

    Fiser R, Masin J, Basler M, Krusek J, Spulakova V, Konopasek I, Sebo P. Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities. J Biol Chem. 2007;282:2808-2820.

    Not in our library10.1074/jbc.m609979200

  117. 117.

    Fong KP, Chung WO, Lamont RJ, Demuth DR. Intra- and interspecies regulation of gene expression by Actinobacillus actinomycetemcomitans LuxS. Infect Immun. 2001;69:7625-7634.

    Not in our library10.1128/iai.69.12.7625-7634.2001

  118. 118.

    Fong KP, Pacheco CM, Otis LL, et al. Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity. Cell Microbiol. 2006;8:1753-1767.

    Not in our library10.1111/j.1462-5822.2006.00746.x

  119. 119.

    Ford MJ, Nomellini JF, Smit J. S-layer anchoring and localization of an S-layer associated protease in Caulobacter crescentus. J Bacteriol. 2007;189:2226-2237.

    Not in our library10.1128/jb.01690-06

  120. 120.

    Forestier C, Welch RA. Identification of RTX toxin target cell specificity domains by use of hybrid genes. Infect Immun. 1991;59:4212-4220.

    Not in our library10.1128/iai.59.11.4212-4220.1991

  121. 121.

    Frey J, Kuhnert P. RTX toxins in Pasteurellaceae. Int J Med Microbiol. 2002;292:149-158.

    Not in our library10.1078/1438-4221-00200

  122. 122.

    Frey J, Meier R, Gygi D, Nicolet J. Nucleotide sequence of the hemolysin I gene from Actinobacillus pleuropneumoniae. Infect Immun. 1991;59:3026-3032.

    Not in our library10.1128/iai.59.9.3026-3032.1991

  123. 123.

    Frey J, Beck M, Stucki U, Nicolet J. Analysis of hemolysin operons in Actinobacillus pleuropneumoniae. Gene. 1993a;123:51-58.

    Not in our library10.1016/0378-1119(93)90538-e

  124. 124.

    Frey J, Bosse JT, Chang YF, et al. Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes. J Gen Microbiol. 1993b;139:1723-1728.

    Not in our library10.1099/00221287-139-8-1723

  125. 125.

    Frey J, Kuhn R, Nicolet J. Association of the CAMP phenomenon in Actinobacillus pleuropneumoniae with the RTX toxins ApxI, ApxII and ApxIII. FEMS Microbiol Lett. 1994;124:245-251.

    Not in our library10.1111/j.1574-6968.1994.tb07291.x

  126. 126.

    Friedman RL, Fiederlein RL, Glasser L, Galgiani JN. Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions. Infect Immun. 1987;55:135-140.

    Not in our library10.1128/iai.55.1.135-140.1987

  127. 127.

    Fronzes R, Christie PJ, Waksman G. The structural biology of type IV secretion systems. Nat Rev Microbiol. 2009;7:703-714.

    Not in our library10.1038/nrmicro2218

  128. 128.

    Fullner KJ, Mekalanos JJ. In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J. 2000;19:5315-5323.

    Not in our library10.1093/emboj/19.20.5315

  129. 129.

    Fullner KJ, Lencer WI, Mekalanos JJ. Vibrio cholerae-induced cellular responses of polarized T84 intestinal epithelial cells are dependent on production of cholera toxin and the RTX toxin. Infect Immun. 2001;69:6310-6317.

    Not in our library10.1128/iai.69.10.6310-6317.2001

  130. 130.

    Fullner KJ, Boucher JC, Hanes MA, et al. The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J Exp Med. 2002;195:1455-1462.

    Not in our library10.1084/jem.20020318

  131. 131.

    Gadeberg OV, Orskov I. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Infect Immun. 1984;45:255-260.

    Not in our library10.1128/iai.45.1.255-260.1984

  132. 132.

    Gangola P, Rosen BP. Maintenance of intracellular calcium in Escherichia coli. J Biol Chem. 1987;262:12570-12574.

    Not in our library

  133. 133.

    Gentile F, Raptis A, Knipling LG, Wolff J. Bordetella pertussis adenylate cyclase. Penetration into host cells. Eur J Biochem. 1988;175:447-453.

    Not in our library10.1111/j.1432-1033.1988.tb14215.x

  134. 134.

    Gentschev I, Hess J, Goebel W. Change in the cellular localization of alkaline phosphatase by alteration of its carboxy-terminal sequence. Mol Gen Genet. 1990;222:211-216.

    Not in our library10.1007/bf00633820

  135. 135.

    Ghigo JM, Wandersman C. Cloning, nucleotide sequence and characterization of the gene encoding the Erwinia chrysanthemi B374 PrtA metalloprotease: a third metalloprotease secreted via a C-terminal secretion signal. Mol Gen Genet. 1992;236:135-144.

    Not in our library10.1007/bf00279652

  136. 136.

    Gilchrist A, Fisher JA, Smit J. Nucleotide sequence analysis of the gene encoding the Caulobacter crescentus paracrystalline surface layer protein. Can J Microbiol. 1992;38:193-202.

    Not in our library10.1139/m92-033

  137. 137.

    Gioia J, Qin X, Jiang H, et al. The genome sequence of Mannheimia haemolytica A1: insights into virulence, natural competence, and Pasteurellaceae phylogeny. J Bacteriol. 2006;188:7257-7266.

    Not in our library10.1128/jb.00675-06

  138. 138.

    Glaser P, Ladant D, Sezer O, Pichot F, Ullmann A, Danchin A. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol Microbiol. 1988a;2:19-30.

    Not in our library

  139. 139.

    Glaser P, Sakamoto H, Bellalou J, Ullmann A, Danchin A. Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-hemolysin bifunctional protein of Bordetella pertussis. EMBO J. 1988b;7:3997-4004.

    Not in our library10.1002/j.1460-2075.1988.tb03288.x

  140. 140.

    Goebel W, Hedgpeth J. Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli. J Bacteriol. 1982;151:1290-1298.

    Not in our library10.1128/jb.151.3.1290-1298.1982

  141. 141.

    Gopinath RS, Ambagala TC, Deshpande MS, Donis RO, Srikumaran S. Mannheimia (Pasteurella) haemolytica leukotoxin binding domain lies within amino acids 1 to 291 of bovine CD18. Infect Immun. 2005;73:6179-6182.

    Not in our library10.1128/iai.73.9.6179-6182.2005

  142. 142.

    Gordon VM, Leppla SH, Hewlett EL. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun. 1988;56:1066-1069.

    Not in our library10.1128/iai.56.5.1066-1069.1988

  143. 143.

    Gray M, Szabo G, Otero AS, Gray L, Hewlett E. Distinct mechanisms for K+ efflux, intoxication, and hemolysis by Bordetella pertussis AC toxin. J Biol Chem. 1998;273:18260-18267.

    Not in our library10.1074/jbc.273.29.18260

  144. 144.

    Gray MC, Donato GM, Jones FR, Kim T, Hewlett EL. Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis. Mol Microbiol. 2004;53:1709-1719.

    Not in our library10.1111/j.1365-2958.2004.04227.x

  145. 145.

    Gueirard P, Druilhe A, Pretolani M, Guiso N. Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun. 1998;66:1718-1725.

    Not in our library10.1128/iai.66.4.1718-1725.1998

  146. 146.

    Guermonprez P, Ladant D, Karimova G, Ullmann A, Leclerc C. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J Immunol. 1999;162:1910-1916.

    Not in our library

  147. 147.

    Guermonprez P, Khelef N, Blouin E, et al. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med. 2001;193:1035-1044.

    Not in our library10.1084/jem.193.9.1035

  148. 148.

    Guo Q, Shen Y, Lee YS, Gibbs CS, Mrksich M, Tang WJ. Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin. EMBO J. 2005;24:3190-3201.

    Not in our library10.1038/sj.emboj.7600800

  149. 149.

    Guzzo J, Murgier M, Filloux A, Lazdunski A. Cloning of the Pseudomonas aeruginosa alkaline protease gene and secretion of the protease into the medium by Escherichia coli. J Bacteriol. 1990;172:942-948.

    Not in our library10.1128/jb.172.2.942-948.1990

  150. 150.

    Hackett M, Guo L, Shabanowitz J, Hunt DF, Hewlett EL. Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science. 1994;266:433-435.

    Not in our library10.1126/science.7939682

  151. 151.

    Hackett M, Walker CB, Guo L, et al. Hemolytic, but not cell-invasive activity, of adenylate cyclase toxin is selectively affected by differential fatty-acylation in Escherichia coli. J Biol Chem. 1995;270:20250-20253.

    Not in our library10.1074/jbc.270.35.20250

  152. 152.

    Haft DH, Selengut JD, White O. The TIGRFAMs database of protein families. Nucleic Acids Res. 2003;31:371-373.

    Not in our library10.1093/nar/gkg128

  153. 153.

    Hanski E. Invasive adenylate cyclase toxin of Bordetella pertussis. Trends Biochem Sci. 1989;14:459-463.

    Not in our library10.1016/0968-0004(89)90106-0

  154. 154.

    Hanski E, Farfel Z. Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration. J Biol Chem. 1985;260:5526-5532.

    Not in our library

  155. 155.

    Haubek D, Havemose-Poulsen A, Westergaard J. Aggressive periodontitis in a 16-year-old Ghanaian adolescent, the original source of Actinobacillus actinomycetemcomitans strain HK1651 – a 10-year follow up. Int J Paediatr Dent. 2006;16:370-375.

    Not in our library10.1111/j.1365-263x.2006.00735.x

  156. 156.

    Havlicek V, Higgins L, Chen W, Halada P, Sebo P, Sakamoto H, Hackett M. Mass spectrometric analysis of recombinant adenylate cyclase toxin from Bordetella pertussis strain 18323/pHSP9. J Mass Spectrom. 2001;36:384-391.

    Not in our library10.1002/jms.139

  157. 157.

    Heck LW, Morihara K, Abrahamson DR. Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease. Infect Immun. 1986;54:149-153.

    Not in our library10.1128/iai.54.1.149-153.1986

  158. 158.

    Henderson B, Nair SP, Ward JM, Wilson M. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol. 2003;57:29-55.

    Not in our library10.1146/annurev.micro.57.030502.090908

  159. 159.

    Hess JF, Angelos JA. The Moraxella bovis RTX toxin locus mbx defines a pathogenicity island. J Med Microbiol. 2006;55:443-449.

    Not in our library10.1099/jmm.0.46366-0

  160. 160.

    Hewlett EL, Donato GM, Gray MC. Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol Microbiol. 2006;59:447-459.

    Not in our library10.1111/j.1365-2958.2005.04958.x

  161. 161.

    Highlander SK, Fedorova ND, Dusek DM, Panciera R, Alvarez LE, Rinehart C. Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model. Infect Immun. 2000;68:3916-3922.

    Not in our library10.1128/iai.68.7.3916-3922.2000

  162. 162.

    Hoiczyk E. Gliding motility in cyanobacteria: observations and possible explanations. Arch Microbiol. 2000;174:11-17.

    Not in our library10.1007/s002030000187

  163. 163.

    Hoiczyk E, Baumeister W. Oscillin, an extracellular, Ca2+-binding glycoprotein essential for the gliding motility of cyanobacteria. Mol Microbiol. 1997;26:699-708.

    Not in our library10.1046/j.1365-2958.1997.5971972.x

  164. 164.

    Hong YQ, Ghebrehiwet B. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin Immunol Immunop. 1992;62:133-138.

    Not in our library10.1016/0090-1229(92)90065-v

  165. 165.

    Hooper NM. Families of zinc metalloproteases. FEBS Lett. 1994;354:1-6.

    Not in our library10.1016/0014-5793(94)01079-x

  166. 166.

    Horvat RT, Parmely MJ. Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity. Infect Immun. 1988;56:2925-2932.

    Not in our library10.1128/iai.56.11.2925-2932.1988

  167. 167.

    Hritz M, Fisher E, Demuth DR. Differential regulation of the leukotoxin operon in highly leukotoxic and minimally leukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun. 1996;64:2724-2729.

    Not in our library10.1128/iai.64.7.2724-2729.1996

  168. 168.

    Hsuan SL, Kannan MS, Jeyaseelan S, Prakash YS, Sieck GC, Maheswaran SK. Pasteurella haemolytica A1-derived leukotoxin and endotoxin induce intracellular calcium elevation in bovine alveolar macrophages by different signaling pathways. Infect Immun. 1998;66:2836-2844.

    Not in our library10.1128/iai.66.6.2836-2844.1998

  169. 169.

    Hsuan SL, Kannan MS, Jeyaseelan S, et al. Pasteurella haemolytica leukotoxin and endotoxin induced cytokine gene expression in bovine alveolar macrophages requires NF-kappaB activation and calcium elevation. Microb Pathogenesis. 1999;26:263-273.

    Not in our library10.1006/mpat.1998.0271

  170. 170.

    Hulo N, Bairoch A, Bulliard V, et al. The PROSITE database. Nucleic Acids Res. 2006;34:D227-D230.

    Not in our library10.1093/nar/gkj063

  171. 171.

    Hyland C, Vuillard L, Hughes C, Koronakis V. Membrane interaction of Escherichia coli hemolysin: flotation and insertion-dependent labeling by phospholipid vesicles. J Bacteriol. 2001;183:5364-5370.

    Not in our library10.1128/jb.183.18.5364-5370.2001

  172. 172.

    Inoue T, Tanimoto I, Tada T, Ohashi T, Fukui K, Ohta H. Fermentable-sugar-level-dependent regulation of leukotoxin synthesis in a variably toxic strain of Actinobacillus actinomycetemcomitans. Microbiology. 2001;147:2749-2756.

    Not in our library10.1099/00221287-147-10-2749

  173. 173.

    Issartel JP, Koronakis V, Hughes C. Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation. Nature. 1991;351:759-761.

    Not in our library10.1038/351759a0

  174. 174.

    Iwaki M, Ullmann A, Sebo P. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin. Mol Microbiol. 1995;17:1015-1024.

    Not in our library10.1111/j.1365-2958.1995.mmi_17061015.x

  175. 175.

    Iwase M, Lally ET, Berthold P, Korchak HM, Taichman NS. Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun. 1990;58:1782-1788.

    Not in our library10.1128/iai.58.6.1782-1788.1990

  176. 176.

    Jacob F, Blobel H, Scharmann W. [Typing of Pseudomonas aeruginosa by means of titrated pyocines (author's transl)]. Zentralbl Bakteriol [Orig A]. 1973;224:472-477.

    Not in our library

  177. 177.

    Jaeger KE, Ransac S, Dijkstra BW, Colson C, van Heuvel M, Misset O. Bacterial lipases. FEMS Microbiol Rev. 1994;15:29-63.

    Not in our library10.1111/j.1574-6976.1994.tb00121.x

  178. 178.

    Jansen R, Briaire J, Kamp EM, Gielkens AL, Smits MA. Cloning and characterization of the Actinobacillus pleuropneumoniae-RTX-toxin III (ApxIII) gene. Infect Immun. 1993;61:947-954.

    Not in our library10.1128/iai.61.3.947-954.1993

  179. 179.

    Jeyaseelan S, Hsuan SL, Kannan MS, et al. Lymphocyte function-associated antigen 1 is a receptor for Pasteurella haemolytica leukotoxin in bovine leukocytes. Infect Immun. 2000;68:72-79.

    Not in our library10.1128/iai.68.1.72-79.2000

  180. 180.

    Jeyaseelan S, Kannan MS, Hsuan SL, Singh AK, Walseth TF, Maheswaran SK. Pasteurella (Mannheimia) haemolytica leukotoxin-induced cytolysis of bovine leukocytes: role of arachidonic acid and its regulation. Microb Pathogenesis. 2001;30:59-69.

    Not in our library10.1006/mpat.2000.0410

  181. 181.

    Jeyaseelan S, Sreevatsan S, Maheswaran SK. Role of Mannheimia haemolytica leukotoxin in the pathogenesis of bovine pneumonic pasteurellosis. Anim Health Res Rev. 2002;3:69-82.

    Not in our library10.1079/ahrr200242

  182. 182.

    Jiang Z, Zheng Y, Luo Y, Wang G, Wang H, Ma Y, Wei D. Cloning and expression of a novel lipase gene from Pseudomonas fluorescens B52. Mol Biotechnol. 2005;31:95-101.

    Not in our library10.1385/mb:31:2:095

  183. 183.

    Johansson A, Claesson R, Hanstrom L, Sandstrom G, Kalfas S. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J Periodontal Res. 2000;35:85-92.

    Not in our library10.1034/j.1600-0765.2000.035002085.x

  184. 184.

    Johnson LA, Beacham IR, MacRae IC, Free ML. Degradation of triglycerides by a pseudomonad isolated from milk: molecular analysis of a lipase-encoding gene and its expression in Escherichia coli. Appl Environ Microb. 1992;58:1776-1779.

    Not in our library10.1128/aem.58.5.1776-1779.1992

  185. 185.

    Jorgensen SE, Mulcahy PF, Wu GK, Louis CF. Calcium accumulation in human and sheep erythrocytes that is induced by Escherichia coli hemolysin. Toxicon. 1983;21:717-727.

    Not in our library10.1016/0041-0101(83)90277-5

  186. 186.

    Kachlany SC, Fine DH, Figurski DH. Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans. Infect Immun. 2000;68:6094-6100.

    Not in our library10.1128/iai.68.11.6094-6100.2000

  187. 187.

    Kachlany SC, Planet PJ, DeSalle R, Fine DH, Figurski DH. Genes for tight adherence of Actinobacillus actinomycetemcomitans: from plaque to plague to pond scum. Trends Microbiol. 2001;9:429-437.

    Not in our library10.1016/s0966-842x(01)02161-8

  188. 188.

    Kaehler KL, Markham RJ, Muscoplat CC, Johnson DW. Evidence of species specificity in the cytocidal effects of Pasteurella haemolytica. Infect Immun. 1980;30:615-616.

    Not in our library10.1128/iai.30.2.615-616.1980

  189. 189.

    Kamanova J, Kofronova O, Masin J, et al. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling. J Immunol. 2008;181:5587-5597.

    Not in our library10.4049/jimmunol.181.8.5587

  190. 190.

    Karakelian D, Lear JD, Lally ET, Tanaka JC. Characterization of Actinobacillus actinomycetemcomitans leukotoxin pore formation in HL60 cells. Biochim Biophys Acta. 1998;1406:175-187.

    Not in our library10.1016/s0925-4439(98)00002-7

  191. 191.

    Karimova G, Pidoux J, Ullmann A, Ladant D. A bacterial two-hybrid system based on a reconstituted signal transduction pathway. P Natl Acad Sci USA. 1998;95:5752-5756.

    Not in our library10.1073/pnas.95.10.5752

  192. 192.

    Kato S, Muro M, Akifusa S, et al. Evidence for apoptosis of murine macrophages by Actinobacillus actinomycetemcomitans infection. Infect Immun. 1995;63:3914-3919.

    Not in our library10.1128/iai.63.10.3914-3919.1995

  193. 193.

    Kato S, Kowashi Y, Demuth DR. Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb Pathogenesis. 2002;32:1-13.

    Not in our library10.1006/mpat.2001.0474

  194. 194.

    Kawai E, Akatsuka H, Idei A, Shibatani T, Omori K. Serratia marcescens S-layer protein is secreted extracellularly via an ATP-binding cassette exporter, the Lip system. Mol Microbiol. 1998;27:941-952.

    Not in our library10.1046/j.1365-2958.1998.00739.x

  195. 195.

    Kawai E, Idei A, Kumura H, Shimazaki K, Akatsuka H, Omori K. The ABC-exporter genes involved in the lipase secretion are clustered with the genes for lipase, alkaline protease, and serine protease homologues in Pseudomonas fluorescens no. 33. Biochim Biophys Acta. 1999;1446:377-382.

    Not in our library10.1016/s0167-4781(99)00094-9

  196. 196.

    Keane WF, Welch R, Gekker G, Peterson PK. Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am J Pathol. 1987;126:350-357.

    Not in our library

  197. 197.

    Kehl-Fie TE, St Geme JW. Identification and characterization of an RTX toxin in the emerging pathogen Kingella kingae. J Bacteriol. 2007;189:430-436.

    Not in our library10.1128/jb.01319-06

  198. 198.

    Kelk P, Johansson A, Claesson R, Hanstrom L, Kalfas S. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun. 2003;71:4448-4455.

    Not in our library10.1128/iai.71.8.4448-4455.2003

  199. 199.

    Kelk P, Claesson R, Hanstrom L, Lerner UH, Kalfas S, Johansson A. Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun. 2005;73:453-458.

    Not in our library10.1128/iai.73.1.453-458.2005

  200. 200.

    Kelk P, Claesson R, Chen C, Sjostedt A, Johansson A. IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. Int J Med Microbiol. 2008;298:529-541.

    Not in our library10.1016/j.ijmm.2007.06.005

  201. 201.

    Kenny B, Haigh R, Holland IB. Analysis of the haemolysin transport process through the secretion from Escherichia coli of PCM, CAT or beta-galactosidase fused to the Hly C-terminal signal domain. Mol Microbiol. 1991;5:2557-2568.

    Not in our library10.1111/j.1365-2958.1991.tb02102.x

  202. 202.

    Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 2004;23:4538-4549.

    Not in our library10.1038/sj.emboj.7600471

  203. 203.

    Khelef N, Guiso N. Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin. FEMS Microbiol Lett. 1995;134:27-32.

    Not in our library10.1111/j.1574-6968.1995.tb07909.x

  204. 204.

    Khelef N, Zychlinsky A, Guiso N. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun. 1993;61:4064-4071.

    Not in our library10.1128/iai.61.10.4064-4071.1993

  205. 205.

    Kieba IR, Fong KP, Tang HY, Hoffman KE, Speicher DW, Klickstein LB, Lally ET. Aggregatibacter actinomycetemcomitans leukotoxin requires beta-sheets 1 and 2 of the human CD11a beta-propeller for cytotoxicity. Cell Microbiol. 2007;9:2689-2699.

    Not in our library10.1111/j.1462-5822.2007.00989.x

  206. 206.

    Kim KS, Kim TU, Kim IJ, Byun SM, Shin YC. Characterization of a metalloprotease inhibitor protein (SmaPI) of Serratia marcescens. Appl Environ Microb. 1995;61:3035-3041.

    Not in our library10.1128/aem.61.8.3035-3041.1995

  207. 207.

    Kim YR, Lee SE, Kook H, et al. Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell Microbiol. 2007;10:848-862.

    Not in our library10.1111/j.1462-5822.2007.01088.x

  208. 208.

    Kojima Y, Shimizu S. Purification and characterization of the lipase from Pseudomonas fluorescens HU380. J Biosci Bioeng. 2003;96:219-226.

    Not in our library

  209. 209.

    Kojima Y, Kobayashi M, Shimizu S. A novel lipase from Pseudomonas fluorescens HU380: gene cloning, overproduction, renaturation-activation, two-step purification, and characterization. J Biosci Bioeng. 2003;96:242-249.

    Not in our library10.1016/s1389-1723(03)80188-3

  210. 210.

    Kolodrubetz D, Phillips L, Jacobs C, Burgum A, Kraig E. Anaerobic regulation of Actinobacillus actinomycetemcomitans leukotoxin transcription is ArcA/FnrA-independent and requires a novel promoter element. Res Microbiol. 2003;154:645-653.

    Not in our library10.1016/j.resmic.2003.09.001

  211. 211.

    Koronakis E, Hughes C, Milisav I, Koronakis V. Protein exporter function and in vitro ATPase activity are correlated in ABC-domain mutants of HlyB. Mol Microbiol. 1995;16:87-96.

    Not in our library10.1111/j.1365-2958.1995.tb02394.x

  212. 212.

    Koronakis V, Cross M, Senior B, Koronakis E, Hughes C. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J Bacteriol. 1987;169:1509-1515.

    Not in our library10.1128/jb.169.4.1509-1515.1987

  213. 213.

    Koronakis V, Hughes C, Koronakis E. Energetically distinct early and late stages of HlyB/HlyD-dependent secretion across both Escherichia coli membranes. EMBO J. 1991;10:3263-3272.

    Not in our library10.1002/j.1460-2075.1991.tb04890.x

  214. 214.

    Koronakis V, Hughes C, Koronakis E. ATPase activity and ATP/ADP-induced conformational change in the soluble domain of the bacterial protein translocator HlyB. Mol Microbiol. 1993;8:1163-1175.

    Not in our library10.1111/j.1365-2958.1993.tb01661.x

  215. 215.

    Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature. 2000;405:914-919.

    Not in our library10.1038/35016007

  216. 216.

    Koronakis V, Eswaran J, Hughes C. Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu Rev Biochem. 2004;73:467-489.

    Not in our library10.1146/annurev.biochem.73.011303.074104

  217. 217.

    Korostoff J, Yamaguchi N, Miller M, Kieba I, Lally ET. Perturbation of mitochondrial structure and function plays a central role in Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Microb Pathogenesis. 2000;29:267-278.

    Not in our library10.1006/mpat.2000.0390

  218. 218.

    Koschinski A, Repp H, Unver B, et al. Why Escherichia coli alpha-hemolysin induces calcium oscillations in mammalian cells – the pore is on its own. FASEB J. 2006;20:973-975.

    Not in our library10.1096/fj.05-4561fje

  219. 219.

    Koval SF, Hynes SH. Effect of paracrystalline protein surface layers on predation by Bdellovibrio bacteriovorus. J Bacteriol. 1991;173:2244-2249.

    Not in our library10.1128/jb.173.7.2244-2249.1991

  220. 220.

    Kreger AS, Gray LD. Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage. Infect Immun. 1978;19:630-648.

    Not in our library10.1128/iai.19.2.630-648.1978

  221. 221.

    Kudryashov DS, Cordero CL, Reisler E, Satchell KJ. Characterization of the enzymatic activity of the actin cross-linking domain from the Vibrio cholerae MARTXVc toxin. J Biol Chem. 2008a;283:445-452.

    Not in our library10.1074/jbc.m703910200

  222. 222.

    Kudryashov DS, Durer ZA, Ytterberg AJ, et al. Connecting actin monomers by iso-peptide bond is a toxicity mechanism of the Vibrio cholerae MARTX toxin. P Natl Acad Sci USA. 2008b;105:18537-18542.

    Not in our library10.1073/pnas.0808082105

  223. 223.

    Kuhnert P, Heyberger-Meyer B, Burnens AP, Nicolet J, Frey J. Detection of RTX toxin genes in gram-negative bacteria with a set of specific probes. Appl Environ Microb. 1997;63:2258-2265.

    Not in our library10.1128/aem.63.6.2258-2265.1997

  224. 224.

    Kuhnert P, Heyberger-Meyer B, Nicolet J, Frey J. Characterization of PaxA and its operon: a cohemolytic RTX toxin determinant from pathogenic Pasteurella aerogenes. Infect Immun. 2000;68:6-12.

    Not in our library10.1128/iai.68.1.6-12.2000

  225. 225.

    Kuhnert P, Schlatter Y, Frey J. Characterization of the type I secretion system of the RTX toxin ApxII in ‘Actinobacillus porcitonsillarum’. Vet Microbiol. 2005;107:225-232.

    Not in our library10.1016/j.vetmic.2005.01.020

  226. 226.

    Kumura H, Hirose S, Sakurai H, Mikawa K, Tomita F, Shimazaki K. Molecular cloning and analysis of a lipase gene from Pseudomonas fluorescens No. 33. Biosci Biotech Bioch. 1998;62:2233-2235.

    Not in our library10.1271/bbb.62.2233

  227. 227.

    LaGier MJ, Threadgill DS. Identification of novel genes in the oral pathogen Campylobacter rectus. Oral Microbiol Immun. 2008;23:406-412.

    Not in our library10.1111/j.1399-302x.2008.00443.x

  228. 228.

    Lally ET, Golub EE, Kieba IR, et al. Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins. J Biol Chem. 1989;264:15451-15456.

    Not in our library

  229. 229.

    Lally ET, Golub EE, Kieba IR, et al. Structure and function of the B and D genes of the Actinobacillus actinomycetemcomitans leukotoxin complex. Microb Pathogenesis. 1991a;11:111-121.

    Not in our library10.1016/0882-4010(91)90004-t

  230. 230.

    Lally ET, Kieba IR, Taichman NS, et al. Actinobacillus actinomycetemcomitans leukotoxin is a calcium-binding protein. J Periodontal Res. 1991b;26:268-271.

    Not in our library10.1111/j.1600-0765.1991.tb01655.x

  231. 231.

    Lally ET, Golub EE, Kieba IR. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. J Biol Chem. 1994;269:31289-31295.

    Not in our library

  232. 232.

    Lally ET, Kieba IR, Sato A, et al. RTX toxins recognize a beta2 integrin on the surface of human target cells. J Biol Chem. 1997;272:30463-30469.

    Not in our library10.1074/jbc.272.48.30463

  233. 233.

    Lear JD, Furblur UG, Lally ET, Tanaka JC. Actinobacillus actinomycetemcomitans leukotoxin forms large conductance, voltage-gated ion channels when incorporated into planar lipid bilayers. Biochim Biophys Acta. 1995;1238:34-41.

    Not in our library10.1016/0005-2736(95)00086-i

  234. 234.

    Lee BC, Lee JH, Kim MW, et al. Vibrio vulnificus rtxE is important for virulence, and its expression is induced by exposure to host cells. Infect Immun. 2008;76:1509-1517.

    Not in our library10.1128/iai.01503-07

  235. 235.

    Lee JH, Kim MW, Kim BS, Kim SM, Lee BC, Kim TS, Choi SH. Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol. 2007;45:146-152.

    Not in our library

  236. 236.

    Leite F, Brown JF, Sylte MJ, Briggs RE, Czuprynski CJ. Recombinant bovine interleukin-1beta amplifies the effects of partially purified Pasteurella haemolytica leukotoxin on bovine neutrophils in a beta(2)-integrin-dependent manner. Infect Immun. 2000;68:5581-5586.

    Not in our library10.1128/iai.68.10.5581-5586.2000

  237. 237.

    Letoffe S, Delepelaire P, Wandersman C. Characterization of a protein inhibitor of extracellular proteases produced by Erwinia chrysanthemi. Mol Microbiol. 1989;3:79-86.

    Not in our library10.1111/j.1365-2958.1989.tb00106.x

  238. 238.

    Letoffe S, Delepelaire P, Wandersman C. Protease secretion by Erwinia chrysanthemi: the specific secretion functions are analogous to those of Escherichia coli alpha-haemolysin. EMBO J. 1990;9:1375-1382.

    Not in our library10.1002/j.1460-2075.1990.tb08252.x

  239. 239.

    Letoffe S, Delepelaire P, Wandersman C. Protein secretion in gram-negative bacteria: assembly of the three components of ABC protein-mediated exporters is ordered and promoted by substrate binding. EMBO J. 1996;15:5804-5811.

    Not in our library

  240. 240.

    Li J, Clinkenbeard KD, Ritchey JW. Bovine CD18 identified as a species specific receptor for Pasteurella haemolytica leukotoxin. Vet Microbiol. 1999;67:91-97.

    Not in our library10.1016/s0378-1135(99)00040-1

  241. 241.

    Li L, Rock JL, Nelson DR. Identification and characterization of a repeat-in-toxin gene cluster in Vibrio anguillarum. Infect Immun. 2008;76:2620-2632.

    Not in our library10.1128/iai.01308-07

  242. 242.

    Li X, Tetling S, Winkler UK, Jaeger KE, Benedik MJ. Gene cloning, sequence analysis, purification, and secretion by Escherichia coli of an extracellular lipase from Serratia marcescens. Appl Environ Microb. 1995;61:2674-2680.

    Not in our library10.1128/aem.61.7.2674-2680.1995

  243. 243.

    Liao CH, McCallus DE. Biochemical and genetic characterization of an extracellular protease from Pseudomonas fluorescens CY091. Appl Environ Microb. 1998;64:914-921.

    Not in our library10.1128/aem.64.3.914-921.1998

  244. 244.

    Lim KB, Walker CR, Guo L, et al. Escherichia coli alpha-hemolysin (HlyA) is heterogeneously acylated in vivo with 14-, 15-, and 17-carbon fatty acids. J Biol Chem. 2000;275:36698-36702.

    Not in our library10.1074/jbc.c000544200

  245. 245.
  246. 246.

    Liu J, Chen X, Tan C, et al. In vivo induced RTX toxin ApxIVA is essential for the full virulence of Actinobacillus pleuropneumoniae. Vet Microbiol. 2009;137:282-289.

    Not in our library10.1016/j.vetmic.2009.01.011

  247. 247.

    Liu M, Alice AF, Naka H, Crosa JH. The HlyU protein is a positive regulator of rtxA1, a gene responsible for cytotoxicity and virulence in the human pathogen Vibrio vulnificus. Infect Immun. 2007;75:3282-3289.

    Not in our library10.1128/iai.00045-07

  248. 248.

    Lo RY, Strathdee CA, Shewen PE. Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1. Infect Immun. 1987;55:1987-1996.

    Not in our library10.1128/iai.55.9.1987-1996.1987

  249. 249.

    Loomes LM, Kerr MA, Senior BW. The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. J Med Microbiol. 1993;39:225-232.

    Not in our library10.1099/00222615-39-3-225

  250. 250.

    Loucka J, Schlecht G, Vodolanova J, Leclerc C, Sebo P. Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase. Infect Immun. 2002;70:1002-1005.

    Not in our library10.1128/iai.70.2.1002-1005.2002

  251. 251.

    Ludwig A, Vogel M, Goebel W. Mutations affecting activity and transport of haemolysin in Escherichia coli. Mol Gen Genet. 1987;206:238-245.

    Not in our library10.1007/bf00333579

  252. 252.

    Ludwig A, Jarchau T, Benz R, Goebel W. The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca2+-dependent binding to erythrocytes. Mol Gen Genet. 1988;214:553-561.

    Not in our library10.1007/bf00330494

  253. 253.

    Ludwig A, Benz R, Goebel W. Oligomerization of Escherichia coli haemolysin (HlyA) is involved in pore formation. Mol Gen Genet. 1993;241:89-96.

    Not in our library10.1007/bf00280205

  254. 254.

    Ludwig A, Garcia F, Bauer S, Jarchau T, Benz R, Hoppe J, Goebel W. Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli. J Bacteriol. 1996;178:5422-5430.

    Not in our library10.1128/jb.178.18.5422-5430.1996

  255. 255.

    Lupardus PJ, Shen A, Bogyo M, Garcia KC. Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain. Science. 2008;322:265-268.

    Not in our library10.1126/science.1162403

  256. 256.

    MacDonald J, Rycroft AN. Molecular cloning and expression of ptxA, the gene encoding the 120-kilodalton cytotoxin of Actinobacillus pleuropneumoniae serotype 2. Infect Immun. 1992;60:2726-2732.

    Not in our library10.1128/iai.60.7.2726-2732.1992

  257. 257.

    Mackova J, Stasikova J, Kutinova L, et al. Prime/boost immunotherapy of HPV16-induced tumors with E7 protein delivered by Bordetella adenylate cyclase and modified vaccinia virus Ankara. Cancer Immunol Immun. 2006;55:39-46.

    Not in our library10.1007/s00262-005-0700-7

  258. 258.

    Maheswaran SK, Weiss DJ, Kannan MS, Townsend EL, Reddy KR, Whiteley LO, Srikumaran S. Effects of Pasteurella haemolytica A1 leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals. Vet Immunol Immunop. 1992;33:51-68.

    Not in our library10.1016/0165-2427(92)90034-n

  259. 259.

    Maier E, Reinhard N, Benz R, Frey J. Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae. Infect Immun. 1996;64:4415-4423.

    Not in our library10.1128/iai.64.11.4415-4423.1996

  260. 260.

    Majury AL, Shewen PE. The effect of Pasteurella haemolytica A1 leukotoxic culture supernate on the in vitro proliferative response of bovine lymphocytes. Vet Immunol Immunop. 1991;29:41-56.

    Not in our library10.1016/0165-2427(91)90051-d

  261. 261.

    Marchler-Bauer A, Panchenko AR, Shoemaker BA, Thiessen PA, Geer LY, Bryant SH. CDD: a database of conserved domain alignments with links to domain three-dimensional structure. Nucleic Acids Res. 2002;30:281-283.

    Not in our library10.1093/nar/30.1.281

  262. 262.

    Marciel AM, Highlander SK. Use of operon fusions in Mannheimia haemolytica to identify environmental and cis-acting regulators of leukotoxin transcription. Infect Immun. 2001;69:6231-6239.

    Not in our library10.1128/iai.69.10.6231-6239.2001

  263. 263.

    Masin J, Konopasek I, Svobodova J, Sebo P. Different structural requirements for adenylate cyclase toxin interactions with erythrocyte and liposome membranes. Biochim Biophys Acta. 2004;1660:144-154.

    Not in our library

  264. 264.

    Masin J, Basler M, Knapp O, et al. Acylation of lysine 860 allows tight binding and cytotoxicity of Bordetella adenylate cyclase on CD11b-expressing cells. Biochemistry. 2005;44:12759-12766.

    Not in our library10.1021/bi050459b

  265. 265.

    McCarren J, Heuser J, Roth R, Yamada N, Martone M, Brahamsha B. Inactivation of swmA results in the loss of an outer cell layer in a swimming synechococcus strain. J Bacteriol. 2005;187:224-230.

    Not in our library10.1128/jb.187.1.224-230.2005

  266. 266.

    McCarthy CN, Woods RG, Beacham IR. Regulation of the aprX-lipA operon of Pseudomonas fluorescens B52: differential regulation of the proximal and distal genes, encoding protease and lipase, by ompR-envZ. FEMS Microbiol Lett. 2004;241:243-248.

    Not in our library10.1016/j.femsle.2004.10.027

  267. 267.

    Menestrina G, Mackman N, Holland IB, Bhakdi S. Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes. Biochim Biophys Acta. 1987;905:109-117.

    Not in our library10.1016/0005-2736(87)90014-9

  268. 268.

    Menestrina G, Pederzolli C, Dalla Serra M, Bregante M, Gambale F. Permeability increase induced by Escherichia coli hemolysin A in human macrophages is due to the formation of ionic pores: a patch clamp characterization. J Membrane Biol. 1996;149:113-121.

    Not in our library10.1007/s002329900012

  269. 269.

    Miyamoto M, Maeda H, Kitanaka M, Kokeguchi S, Takashiba S, Murayama Y. The S-layer protein from Campylobacter rectus: sequence determination and function of the recombinant protein. FEMS Microbiol Lett. 1998;166:275-281.

    Not in our library10.1111/j.1574-6968.1998.tb13901.x

  270. 270.

    Miyoshi S, Shinoda S. Microbial metalloproteases and pathogenesis. Microbes Infect. 2000;2:91-98.

    Not in our library10.1016/s1286-4579(00)00280-x

  271. 271.

    Moayeri M, Welch RA. Effects of temperature, time, and toxin concentration on lesion formation by the Escherichia coli hemolysin. Infect Immun. 1994;62:4124-4134.

    Not in our library10.1128/iai.62.10.4124-4134.1994

  272. 272.

    Moayeri M, Welch RA. Prelytic and lytic conformations of erythrocyte-associated Escherichia coli hemolysin. Infect Immun. 1997;65:2233-2239.

    Not in our library10.1128/iai.65.6.2233-2239.1997

  273. 273.

    Mobley HL, Green DM, Trifillis AL, et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun. 1990;58:1281-1289.

    Not in our library10.1128/iai.58.5.1281-1289.1990

  274. 274.

    Morova J, Osicka R, Masin J, Sebo P. RTX cytotoxins recognize beta2 integrin receptors through N-linked oligosaccharides. P Natl Acad Sci USA. 2008;105:5355-5360.

    Not in our library10.1073/pnas.0711400105

  275. 275.

    Muller D, Hughes C, Goebel W. Relationship between plasmid and chromosomal hemolysin determinants of Escherichia coli. J Bacteriol. 1983;153:846-851.

    Not in our library10.1128/jb.153.2.846-851.1983

  276. 276.

    Nagahata H. Bovine leukocyte adhesion deficiency (BLAD): a review. J Vet Med Sci. 2004;66:1475-1482.

    Not in our library10.1292/jvms.66.1475

  277. 277.

    Nakahama K, Yoshimura K, Marumoto R, Kikuchi M, Lee IS, Hase T, Matsubara H. Cloning and sequencing of Serratia protease gene. Nucleic Acids Res. 1986;14:5843-5855.

    Not in our library10.1093/nar/14.14.5843

  278. 278.

    Nomellini JF, Kupcu S, Sleytr UB, Smit J. Factors controlling in vitro recrystallization of the Caulobacter crescentus paracrystalline S-layer. J Bacteriol. 1997;179:6349-6354.

    Not in our library10.1128/jb.179.20.6349-6354.1997

  279. 279.

    Nomellini JF, Duncan G, Dorocicz IR, Smit J. S-layer-mediated display of the immunoglobulin G-binding domain of streptococcal protein G on the surface of Caulobacter crescentus: development of an immunoactive reagent. Appl Environ Microb. 2007;73:3245-3253.

    Not in our library10.1128/aem.02900-06

  280. 280.

    Nyarko KA, Coomber BL, Mellors A, Gentry PA. Bovine platelet adhesion is enhanced by leukotoxin and sialoglycoprotease isolated from Pasteurella haemolytica A1 cultures. Vet Microbiol. 1998;61:81-91.

    Not in our library10.1016/s0378-1135(98)00171-0

  281. 281.

    Ohta H, Kato K, Kokeguchi S, Hara H, Fukui K, Murayama Y. Nuclease-sensitive binding of an Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface. Infect Immun. 1991;59:4599-4605.

    Not in our library10.1128/iai.59.12.4599-4605.1991

  282. 282.

    Okuda K, Kigure T, Yamada S, et al. Role for the S-layer of Campylobacter rectus ATCC33238 in complement mediated killing and phagocytic killing by leukocytes from guinea pig and human peripheral blood. Oral Dis. 1997;3:113-120.

    Not in our library10.1111/j.1601-0825.1997.tb00022.x

  283. 283.

    Oresnik IJ, Twelker S, Hynes MF. Cloning and characterization of a Rhizobium leguminosarum gene encoding a bacteriocin with similarities to RTX toxins. Appl Environ Microb. 1999;65:2833-2840.

    Not in our library10.1128/aem.65.7.2833-2840.1999

  284. 284.

    Ortiz-Carranza O, Czuprynski CJ. Activation of bovine neutrophils by Pasteurella haemolytica leukotoxin is calcium dependent. J Leukocyte Biol. 1992;52:558-564.

    Not in our library10.1002/jlb.52.5.558

  285. 285.

    Osicka R, Osickova A, Basar T, Guermonprez P, Rojas M, Leclerc C, Sebo P. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Infect Immun. 2000;68:247-256.

    Not in our library10.1128/iai.68.1.247-256.2000

  286. 286.

    Osicka R, Kalmusova J, Krizova P, Sebo P. Neisseria meningitidis RTX protein FrpC induces high levels of serum antibodies during invasive disease: polymorphism of frpC alleles and purification of recombinant FrpC. Infect Immun. 2001;69:5509-5519.

    Not in our library10.1128/iai.69.9.5509-5519.2001

  287. 287.

    Osicka R, Prochazkova K, Sulc M, Linhartova I, Havlicek V, Sebo P. A novel ‘clip-and-link’ activity of repeat in toxin (RTX) proteins from gram-negative pathogens. Covalent protein cross-linking by an Asp-Lys isopeptide bond upon calcium-dependent processing at an Asp-Pro bond. J Biol Chem. 2004;279:24944-24956.

    Not in our library10.1074/jbc.m314013200

  288. 288.

    Osickova A, Osicka R, Maier E, Benz R, Sebo P. An amphipathic alpha-helix including glutamates 509 and 516 is crucial for membrane translocation of adenylate cyclase toxin and modulates formation and cation selectivity of its membrane channels. J Biol Chem. 1999;274:37644-37650.

    Not in our library

  289. 289.

    Osickova A, Masin J, Fayolle C, et al. Adenylate cyclase toxin translocates across target cell membrane without forming a pore. Mol Microbiol. 2010;75:1550-1562.

    Not in our library10.1111/j.1365-2958.2010.07077.x

  290. 290.

    Ostolaza H, Bakas L, Goni FM. Balance of electrostatic and hydrophobic interactions in the lysis of model membranes by E. coli alpha-haemolysin. J Membrane Biol. 1997;158:137-145.

    Not in our library10.1007/s002329900251

  291. 291.

    Otero AS, Yi XB, Gray MC, Szabo G, Hewlett EL. Membrane depolarization prevents cell invasion by Bordetella pertussis adenylate cyclase toxin. J Biol Chem. 1995;270:9695-9697.

    Not in our library10.1074/jbc.270.17.9695

  292. 292.

    Parkhill J, Achtman M, James KD, et al. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature. 2000;404:502-506.

    Not in our library10.1038/35006655

  293. 293.

    Pellett S, Welch RA. Escherichia coli hemolysin mutants with altered target cell specificity. Infect Immun. 1996;64:3081-3087.

    Not in our library10.1128/iai.64.8.3081-3087.1996

  294. 294.

    Pimenta AL, Racher K, Jamieson L, Blight MA, Holland IB. Mutations in HlyD, part of the type 1 translocator for hemolysin secretion, affect the folding of the secreted toxin. J Bacteriol. 2005;187:7471-7480.

    Not in our library10.1128/jb.187.21.7471-7480.2005

  295. 295.

    Preville X, Ladant D, Timmerman B, Leclerc C. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res. 2005;65:641-649.

    Not in our library

  296. 296.

    Prochazkova K, Satchell KJ. Structure-function analysis of inositol hexakisphosphate-induced autoprocessing of the Vibrio cholerae multifunctional-autoprocessing RTX toxin. J Biol Chem. 2008;35:23656-23664.

    Not in our library10.1074/jbc.m803334200

  297. 297.

    Prochazkova K, Osicka R, Linhartova I, Halada P, Sulc M, Sebo P. The Neisseria meningitidis outer membrane lipoprotein FrpD binds the RTX protein FrpC. J Biol Chem. 2005;280:3251-3258.

    Not in our library10.1074/jbc.m411232200

  298. 298.

    Prochazkova K, Shuvalova LA, Minasov G, Voburka Z, Anderson WF, Satchell KJ. Structural and molecular mechanism for autoprocessing of MARTX toxin of Vibrio cholerae at multiple sites. J Biol Chem. 2009;284:26557-26568.

    Not in our library10.1074/jbc.m109.025510

  299. 299.

    Rashid N, Shimada Y, Ezaki S, Atomi H, Imanaka T. Low-temperature lipase from psychrotrophic Pseudomonas sp. strain KB700A. Appl Environ Microb. 2001;67:4064-4069.

    Not in our library10.1128/aem.67.9.4064-4069.2001

  300. 300.

    Reimer D, Frey J, Jansen R, Veit HP, Inzana TJ. Molecular investigation of the role of ApxI and ApxII in the virulence of Actinobacillus pleuropneumoniae serotype 5. Microb Pathogenesis. 1995;18:197-209.

    Not in our library10.1016/s0882-4010(95)90049-7

  301. 301.

    Rhodes CR, Gray MC, Watson JM, Muratore TL, Kim SB, Hewlett EL, Grisham CM. Structural consequences of divalent metal binding by the adenylyl cyclase toxin of Bordetella pertussis. Arch Biochem Biophys. 2001;395:169-176.

    Not in our library10.1006/abbi.2001.2553

  302. 302.

    Rice P, Longden I, Bleasby A. EMBOSS: the European molecular biology open software suite. Trends Genet. 2000;16:276-277.

    Not in our library10.1016/s0168-9525(00)02024-2

  303. 303.

    Rogers DG, Cheville NF, Pugh GW. Pathogenesis of corneal lesions caused by Moraxella bovis in gnotobiotic calves. Vet Pathol. 1987;24:287-295.

    Not in our library10.1177/030098588702400401

  304. 304.

    Rose T, Sebo P, Bellalou J, Ladant D. Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes. J Biol Chem. 1995;270:26370-26376.

    Not in our library10.1074/jbc.270.44.26370

  305. 305.

    Rycroft AN, Williams D, Cullen JM, Macdonald J. The cytotoxin of Actinobacillus pleuropneumoniae (pleurotoxin) is distinct from the haemolysin and is associated with a 120 kDa polypeptide. J Gen Microbiol. 1991;137:561-568.

    Not in our library10.1099/00221287-137-3-561

  306. 306.

    Sadilkova L, Osicka R, Sulc M, Linhartova I, Novak P, Sebo P. Single-step affinity purification of recombinant proteins using a self-excising module from Neisseria meningitidis FrpC. Protein Sci. 2008;17:1834-1843.

    Not in our library10.1110/ps.035733.108

  307. 307.

    Saier MH, Ma CH, Rodgers L, Tamang DG, Yen MR. Protein secretion and membrane insertion systems in bacteria and eukaryotic organelles. Adv Appl Microbiol. 2008;65:141-197.

    Not in our library10.1016/s0065-2164(08)00606-0

  308. 308.

    Sakiyama T, Ueno H, Homma H, Numata O, Kuwabara T. Purification and characterization of a hemolysin-like protein, Sll1951, a nontoxic member of the RTX protein family from the cyanobacterium Synechocystis sp. strain PCC 6803. J Bacteriol. 2006;188:3535-3542.

    Not in our library10.1128/jb.188.10.3535-3542.2006

  309. 309.

    Sanchez-Magraner L, Viguera AR, Garcia-Pacios M, et al. The calcium-binding C-terminal domain of Escherichia coli alpha-hemolysin is a major determinant in the surface-active properties of the protein. J Biol Chem. 2007;282:11827-11835.

    Not in our library10.1074/jbc.m700547200

  310. 310.

    Saron MF, Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. P Natl Acad Sci USA. 1997;94:3314-3319.

    Not in our library10.1073/pnas.94.7.3314

  311. 311.

    Satchell KJ. MARTX, multifunctional autoprocessing repeats-in-toxin toxins. Infect Immun. 2007;75:5079-5084.

    Not in our library10.1128/iai.00525-07

  312. 312.

    Schaller A, Kuhn R, Kuhnert P, et al. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology. 1999;145:2105-2116.

    Not in our library10.1099/13500872-145-8-2105

  313. 313.

    Schaller A, Kuhnert P, de la Puente-Redondo VA, Nicolet J, Frey J. Apx toxins in Pasteurellaceae species from animals. Vet Microbiol. 2000;74:365-376.

    Not in our library10.1016/s0378-1135(00)00204-2

  314. 314.

    Schindel C, Zitzer A, Schulte B, et al. Interaction of Escherichia coli hemolysin with biological membranes. A study using cysteine scanning mutagenesis. Eur J Biochem. 2001;268:800-808.

    Not in our library10.1046/j.1432-1327.2001.01937.x

  315. 315.

    Schlecht G, Loucka J, Najar H, Sebo P, Leclerc C. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J Immunol. 2004;173:6089-6097.

    Not in our library10.4049/jimmunol.173.10.6089

  316. 316.

    Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun. 1995;63:1055-1061.

    Not in our library10.1128/iai.63.3.1055-1061.1995

  317. 317.

    Schmidt H, Maier E, Karch H, Benz R. Pore-forming properties of the plasmid-encoded hemolysin of enterohemorrhagic Escherichia coli O157:H7. Eur J Biochem. 1996;241:594-601.

    Not in our library10.1111/j.1432-1033.1996.00594.x

  318. 318.

    Sebo P, Ladant D. Repeat sequences in the Bordetella pertussis adenylate cyclase toxin can be recognized as alternative carboxy-proximal secretion signals by the Escherichia coli alpha-haemolysin translocator. Mol Microbiol. 1993;9:999-1009.

    Not in our library10.1111/j.1365-2958.1993.tb01229.x

  319. 319.

    Sebo P, Glaser P, Sakamoto H, Ullmann A. High-level synthesis of active adenylate cyclase toxin of Bordetella pertussis in a reconstructed Escherichia coli system. Gene. 1991;104:19-24.

    Not in our library10.1016/0378-1119(91)90459-o

  320. 320.

    Sebo P, Fayolle C, d'Andria O, Ladant D, Leclerc C, Ullmann A. Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Infect Immun. 1995;63:3851-3857.

    Not in our library10.1128/iai.63.10.3851-3857.1995

  321. 321.

    Shanthalingam S, Srikumaran S. Intact signal peptide of CD18, the beta-subunit of beta2-integrins, renders ruminants susceptible to Mannheimia haemolytica leukotoxin. P Natl Acad Sci USA. 2009;106:15448-15453.

    Not in our library10.1073/pnas.0906775106

  322. 322.

    Sheahan KL, Satchell KJ. Inactivation of small Rho GTPases by the multifunctional RTX toxin from Vibrio cholerae. Cell Microbiol. 2007;9:1324-1335.

    Not in our library10.1111/j.1462-5822.2006.00876.x

  323. 323.

    Sheahan KL, Cordero CL, Satchell KJ. Identification of a domain within the multifunctional Vibrio cholerae RTX toxin that covalently cross-links actin. P Natl Acad Sci USA. 2004;101:9798-9803.

    Not in our library10.1073/pnas.0401104101

  324. 324.

    Shen A, Lupardus PJ, Albrow VE, Guzzetta A, Powers JC, Garcia KC, Bogyo M. Mechanistic and structural insights into the proteolytic activation of Vibrio cholerae MARTX toxin. Nat Chem Biol. 2009;5:469-478.

    Not in our library10.1038/nchembio.178

  325. 325.

    Shewen PE, Wilkie BN. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect Immun. 1982;35:91-94.

    Not in our library10.1128/iai.35.1.91-94.1982

  326. 326.

    Shibuya Y, Yamamoto T, Morimoto T, Nishino N, Kambara T, Okabe H. Pseudomonas aeruginosa alkaline proteinase might share a biological function with plasmin. Biochim Biophys Acta. 1991;1077:316-324.

    Not in our library10.1016/0167-4838(91)90546-c

  327. 327.

    Short EC, Kurtz HJ. Properties of the hemolytic activities of Escherichia coli. Infect Immun. 1971;3:678-687.

    Not in our library10.1128/iai.3.5.678-687.1971

  328. 328.

    Shuster DE, Kehrli ME, Ackermann MR, Gilbert RO. Identification and prevalence of a genetic-defect that causes leukocyte adhesion deficiency in holstein cattle. P Natl Acad Sci USA. 1992;89:9225-9229.

    Not in our library10.1073/pnas.89.19.9225

  329. 329.

    Simpson AJ, Reinach FC, Arruda P, et al. The genome sequence of the plant pathogen Xylella fastidiosa. The Xylella fastidiosa Consortium of the Organization for Nucleotide Sequencing and Analysis. Nature. 2000;406:151-159.

    Not in our library10.1038/35018003

  330. 330.

    Simpson DL, Berthold P, Taichman NS. Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun. 1988;56:1162-1166.

    Not in our library10.1128/iai.56.5.1162-1166.1988

  331. 331.

    Skals M, Jorgensen NR, Leipziger J, Praetorius HA. Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. P Natl Acad Sci USA. 2009;106:4030-4035.

    Not in our library10.1073/pnas.0807044106

  332. 332.

    Sleytr UB, Beveridge TJ. Bacterial S-layers. Trends Microbiol. 1999;7:253-260.

    Not in our library10.1016/s0966-842x(99)01513-9

  333. 333.

    Sleytr UB, Egelseer EM, Ilk N, Pum D, Schuster B. S-layers as a basic building block in a molecular construction kit. FEBS J. 2007;274:323-334.

    Not in our library10.1111/j.1742-4658.2006.05606.x

  334. 334.

    Smit J, Engelhardt H, Volker S, Smith SH, Baumeister W. The S-layer of Caulobacter crescentus: three-dimensional image reconstruction and structure analysis by electron microscopy. J Bacteriol. 1992;174:6527-6538.

    Not in our library10.1128/jb.174.20.6527-6538.1992

  335. 335.

    Soloaga A, Ostolaza H, Goni FM, de la Cruz F. Purification of Escherichia coli pro-haemolysin, and a comparison with the properties of mature alpha-haemolysin. Eur J Biochem. 1996;238:418-422.

    Not in our library10.1111/j.1432-1033.1996.0418z.x

  336. 336.

    Sory MP, Cornelis GR. Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol. 1994;14:583-594.

    Not in our library10.1111/j.1365-2958.1994.tb02191.x

  337. 337.

    Spitznagel J, Kraig E, Kolodrubetz D. The regulation of leukotoxin production in Actinobacillus actinomycetemcomitans strain JP2. Adv Dent Res. 1995;9:48-54.

    Not in our library10.1177/08959374950090010901

  338. 338.

    Stanley P, Koronakis V, Hughes C. Mutational analysis supports a role for multiple structural features in the C-terminal secretion signal of Escherichia coli haemolysin. Mol Microbiol. 1991;5:2391-2403.

    Not in our library10.1111/j.1365-2958.1991.tb02085.x

  339. 339.

    Stanley P, Packman LC, Koronakis V, Hughes C. Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin. Science. 1994;266:1992-1996.

    Not in our library10.1126/science.7801126

  340. 340.

    Stanley P, Koronakis V, Hughes C. Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function. Microbiol Mol Biol R. 1998;62:309-333.

    Not in our library10.1128/mmbr.62.2.309-333.1998

  341. 341.

    Stanley PL, Diaz P, Bailey MJ, Gygi D, Juarez A, Hughes C. Loss of activity in the secreted form of Escherichia coli haemolysin caused by an rfaP lesion in core lipopolysaccharide assembly. Mol Microbiol. 1993;10:781-787.

    Not in our library10.1111/j.1365-2958.1993.tb00948.x

  342. 342.

    Stern RV, Howard GT. The polyester polyurethanase gene (pueA) from Pseudomonas chlororaphis encodes a lipase. FEMS Microbiol Lett. 2000;185:163-168.

    Not in our library10.1111/j.1574-6968.2000.tb09056.x

  343. 343.

    Stevens P, Czuprynski C. Dissociation of cytolysis and monokine release by bovine mononuclear phagocytes incubated with Pasteurella haemolytica partially purified leukotoxin and lipopolysaccharide. Can J Vet Res. 1995;59:110-117.

    Not in our library

  344. 344.

    Stocker W, Bode W. Structural features of a superfamily of zinc-endopeptidases: the metzincins. Curr Opin Struc Biol. 1995;5:383-390.

    Not in our library10.1016/0959-440x(95)80101-4

  345. 345.

    Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB, Bode W. The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 1995;4:823-840.

    Not in our library10.1002/pro.5560040502

  346. 346.

    Strathdee CA, Lo RY. Extensive homology between the leukotoxin of Pasteurella haemolytica A1 and the alpha-hemolysin of Escherichia coli. Infect Immun. 1987;55:3233-3236.

    Not in our library10.1128/iai.55.12.3233-3236.1987

  347. 347.

    Strathdee CA, Lo RY. Cloning, nucleotide sequence, and characterization of genes encoding the secretion function of the Pasteurella haemolytica leukotoxin determinant. J Bacteriol. 1989;171:916-928.

    Not in our library10.1128/jb.171.2.916-928.1989

  348. 348.

    Sugawara M, Haramaki R, Nonaka S, et al. Rhizobitoxine production in Agrobacterium tumefaciens C58 by Bradyrhizobium elkanii rtxACDEFG genes. FEMS Microbiol Lett. 2007;269:29-35.

    Not in our library10.1111/j.1574-6968.2006.00590.x

  349. 349.

    Sun Y, Clinkenbeard KD, Cudd LA, Clarke CR, Clinkenbeard PA. Correlation of Pasteurella haemolytica leukotoxin binding with susceptibility to intoxication of lymphoid cells from various species. Infect Immun. 1999;67:6264-6269.

    Not in our library10.1128/iai.67.12.6264-6269.1999

  350. 350.

    Sutton JM, Lea EJ, Downie JA. The nodulation-signaling protein NodO from Rhizobium leguminosarum biovar viciae forms ion channels in membranes. P Natl Acad Sci USA. 1994;91:9990-9994.

    Not in our library10.1073/pnas.91.21.9990

  351. 351.

    Suttorp N, Floer B, Schnittler H, Seeger W, Bhakdi S. Effects of Escherichia coli hemolysin on endothelial cell function. Infect Immun. 1990;58:3796-3801.

    Not in our library10.1128/iai.58.11.3796-3801.1990

  352. 352.

    Syed KA, Beyhan S, Correa N, et al. The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors. J Bacteriol. 2009;191:6555-6570.

    Not in our library10.1128/jb.00949-09

  353. 353.

    Szabo G, Gray MC, Hewlett EL. Adenylate cyclase toxin from Bordetella pertussis produces ion conductance across artificial lipid bilayers in a calcium- and polarity-dependent manner. J Biol Chem. 1994;269:22496-22499.

    Not in our library

  354. 354.

    Taichman NS, Shenker BJ, Tsai CC, Glickman LT, Baehni PC, Stevens R, Hammond BF. Cytopathic effects of Actinobacillus actinomycetemcomitans on monkey blood leukocytes. J Periodontal Res. 1984;19:133-145.

    Not in our library10.1111/j.1600-0765.1984.tb00802.x

  355. 355.

    Taichman NS, Simpson DL, Sakurada S, Cranfield M, DiRienzo J, Slots J. Comparative studies on the biology of Actinobacillus actinomycetemcomitans leukotoxin in primates. Oral Microbiol Immun. 1987;2:97-104.

    Not in our library10.1111/j.1399-302x.1987.tb00270.x

  356. 356.

    Taichman NS, Iwase M, Korchak H, Berthold P, Lally ET. Membranolytic activity of Actinobacillus actinomycetemcomitans leukotoxin. J Periodontal Res. 1991a;26:258-260.

    Not in our library10.1111/j.1600-0765.1991.tb01652.x

  357. 357.

    Taichman NS, Iwase M, Lally ET, Shattil SJ, Cunningham ME, Korchak HM. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells. J Immunol. 1991b;147:3587-3594.

    Not in our library

  358. 358.

    Tan Y, Miller KJ. Cloning, expression, and nucleotide sequence of a lipase gene from Pseudomonas fluorescens B52. Appl Environ Microb. 1992;58:1402-1407.

    Not in our library10.1128/aem.58.4.1402-1407.1992

  359. 359.

    Tettelin H, Saunders NJ, Heidelberg J, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science. 2000;287:1809-1815.

    Not in our library10.1126/science.287.5459.1809

  360. 360.

    Thanabalu T, Koronakis E, Hughes C, Koronakis V. Substrate-induced assembly of a contiguous channel for protein export from E. coli: reversible bridging of an inner-membrane translocase to an outer membrane exit pore. EMBO J. 1998;17:6487-6496.

    Not in our library10.1093/emboj/17.22.6487

  361. 361.

    Thompson SA. Campylobacter surface-layers (S-layers) and immune evasion. Ann Periodontol. 2002;7:43-53.

    Not in our library10.1902/annals.2002.7.1.43

  362. 362.

    Thompson SA, Sparling PF. The RTX cytotoxin-related FrpA protein of Neisseria meningitidis is secreted extracellularly by meningococci and by HlyBD+Escherichia coli. Infect Immun. 1993;61:2906-2911.

    Not in our library10.1128/iai.61.7.2906-2911.1993

  363. 363.

    Thompson SA, Wang LL, Sparling PF. Cloning and nucleotide sequence of frpC, a second gene from Neisseria meningitidis encoding a protein similar to RTX cytotoxins. Mol Microbiol. 1993a;9:85-96.

    Not in our library10.1111/j.1365-2958.1993.tb01671.x

  364. 364.

    Thompson SA, Wang LL, West A, Sparling PF. Neisseria meningitidis produces iron-regulated proteins related to the RTX family of exoproteins. J Bacteriol. 1993b;175:811-818.

    Not in our library10.1128/jb.175.3.811-818.1993

  365. 365.

    Thumbikat P, Briggs RE, Kannan MS, Maheswaran SK. Biological effects of two genetically defined leukotoxin mutants of Mannheimia haemolytica. Microb Pathogenesis. 2003;34:217-226.

    Not in our library10.1016/s0882-4010(03)00033-0

  366. 366.

    Toporowski MC, Nomellini JF, Awram P, Smit J. Two outer membrane proteins are required for maximal type I secretion of the Caulobacter crescentus S-layer protein. J Bacteriol. 2004;186:8000-8009.

    Not in our library10.1128/jb.186.23.8000-8009.2004

  367. 367.

    TranVan Nhieu G, Clair C, Grompone G, Sansonetti P. Calcium signalling during cell interactions with bacterial pathogens. Biol Cell. 2004;96:93-101.

    Not in our library10.1016/j.biolcel.2003.10.006

  368. 368.

    Trent MS, Worsham LM, Ernst-Fonberg ML. The biochemistry of hemolysin toxin activation: characterization of HlyC, an internal protein acyltransferase. Biochemistry. 1998;37:4644-4652.

    Not in our library10.1021/bi971588y

  369. 369.

    Trent MS, Worsham LM, Ernst-Fonberg ML. HlyC, the internal protein acyltransferase that activates hemolysin toxin: role of conserved histidine, serine, and cysteine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis. Biochemistry. 1999a;38:3433-3439.

    Not in our library10.1021/bi982491u

  370. 370.

    Trent MS, Worsham LM, Ernst-Fonberg ML. HlyC, the internal protein acyltransferase that activates hemolysin toxin: the role of conserved tyrosine and arginine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis. Biochemistry. 1999b;38:8831-8838.

    Not in our library10.1021/bi990138y

  371. 371.

    Trent MS, Worsham LM, Ernst-Fonberg ML. HlyC, the internal protein acyltransferase that activates hemolysin toxin: roles of various conserved residues in enzymatic activity as probed by site-directed mutagenesis. Biochemistry. 1999c;38:9541-9548.

    Not in our library10.1021/bi9905617

  372. 372.

    Tsai CC, Shenker BJ, DiRienzo JM, Malamud D, Taichman NS. Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B. Infect Immun. 1984;43:700-705.

    Not in our library10.1128/iai.43.2.700-705.1984

  373. 373.

    Uhlen P, Laestadius A, Jahnukainen T, et al. Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells. Nature. 2000;405:694-697.

    Not in our library10.1038/35015091

  374. 374.

    Umelo-Njaka E, Nomellini JF, Bingle WH, Glasier LG, Irvin RT, Smit J. Expression and testing of Pseudomonas aeruginosa vaccine candidate proteins prepared with the Caulobacter crescentus S-layer protein expression system. Vaccine. 2001;19:1406-1415.

    Not in our library10.1016/s0264-410x(00)00362-5

  375. 375.

    Umelo-Njaka E, Bingle WH, Borchani F, et al. Caulobacter crescentus synthesizes an S-layer-editing metalloprotease possessing a domain sharing sequence similarity with its paracrystalline S-layer protein. J Bacteriol. 2002;184:2709-2718.

    Not in our library10.1128/jb.184.10.2709-2718.2002

  376. 376.

    Valens M, Broutelle AC, Lefebvre M, Blight MA. A zinc metalloprotease inhibitor, Inh, from the insect pathogen Photorhabdus luminescens. Microbiology. 2002;148:2427-2437.

    Not in our library10.1099/00221287-148-8-2427

  377. 377.

    Valeva A, Walev I, Kemmer H, et al. Binding of Escherichia coli hemolysin and activation of the target cells is not receptor-dependent. J Biol Chem. 2005;280:36657-36663.

    Not in our library10.1074/jbc.m507690200

  378. 378.

    Venter AP, Twelker S, Oresnik IJ, Hynes MF. Analysis of the genetic region encoding a novel rhizobiocin from Rhizobium leguminosarum bv. viciae strain 306. Can J Microbiol. 2001;47:495-502.

    Not in our library10.1139/w01-043

  379. 379.

    Venter JC, Remington K, Heidelberg JF, et al. Environmental genome shotgun sequencing of the Sargasso Sea. Science. 2004;304:66-74.

    Not in our library10.1126/science.1093857

  380. 380.

    Vojtova J, Kamanova J, Sebo P. Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr Opin Microbiol. 2006;9:69-75.

    Not in our library10.1016/j.mib.2005.12.011

  381. 381.

    Vojtova-Vodolanova J, Basler M, Osicka R, et al. Oligomerization is involved in pore formation by Bordetella adenylate cyclase toxin. FASEB J. 2009;23:2831-2843.

    Not in our library10.1096/fj.09-131250

  382. 382.

    Wagner W, Vogel M, Goebel W. Transport of hemolysin across the outer membrane of Escherichia coli requires two functions. J Bacteriol. 1983;154:200-210.

    Not in our library10.1128/jb.154.1.200-210.1983

  383. 383.

    Walker KE, Moghaddame-Jafari S, Lockatell CV, Johnson D, Belas R. ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells. Mol Microbiol. 1999;32:825-836.

    Not in our library10.1046/j.1365-2958.1999.01401.x

  384. 384.

    Walker SG, Karunaratne DN, Ravenscroft N, Smit J. Characterization of mutants of Caulobacter crescentus defective in surface attachment of the paracrystalline surface layer. J Bacteriol. 1994;176:6312-6323.

    Not in our library10.1128/jb.176.20.6312-6323.1994

  385. 385.

    Wandersman C, Delepelaire P. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. P Natl Acad Sci USA. 1990;87:4776-4780.

    Not in our library10.1073/pnas.87.12.4776

  386. 386.

    Wandersman C, Delepelaire P, Letoffe S, Schwartz M. Characterization of Erwinia chrysanthemi extracellular proteases: cloning and expression of the protease genes in Escherichia coli. J Bacteriol. 1987;169:5046-5053.

    Not in our library10.1128/jb.169.11.5046-5053.1987

  387. 387.

    Wang B, Kraig E, Kolodrubetz D. A new member of the S-layer protein family: characterization of the crs gene from Campylobacter rectus. Infect Immun. 1998;66:1521-1526.

    Not in our library10.1128/iai.66.4.1521-1526.1998

  388. 388.

    Wassif C, Cheek D, Belas R. Molecular analysis of a metalloprotease from Proteus mirabilis. J Bacteriol. 1995;177:5790-5798.

    Not in our library10.1128/jb.177.20.5790-5798.1995

  389. 389.

    Watson RM, Woody RW, Lewis RV, Bohle DS, Andreotti AH, Ray B, Miller KW. Conformational changes in pediocin AcH upon vesicle binding and approximation of the membrane-bound structure in detergent micelles. Biochemistry. 2001;40:14037-14046.

    Not in our library10.1021/bi011031p

  390. 390.

    Weingart CL, Weiss AA. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect Immun. 2000;68:1735-1739.

    Not in our library10.1128/iai.68.3.1735-1739.2000

  391. 391.

    Weiss AA, Hewlett EL, Myers GA, Falkow S. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis. 1984;150:219-222.

    Not in our library10.1093/infdis/150.2.219

  392. 392.

    Welch RA. Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect Immun. 1987;55:2183-2190.

    Not in our library10.1128/iai.55.9.2183-2190.1987

  393. 393.

    Welch RA. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol. 1991;5:521-528.

    Not in our library10.1111/j.1365-2958.1991.tb00723.x

  394. 394.

    Welch RA. RTX toxin structure and function: a story of numerous anomalies and few analogies in toxin biology. Curr Top Microbiol Immunol. 2001;257:85-111.

    Not in our library10.1007/978-3-642-56508-3_5

  395. 395.

    Westrop G, Hormozi K, da Costa N, Parton R, Coote J. Structure-function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid proteins. J Bacteriol. 1997;179:871-879.

    Not in our library10.1128/jb.179.3.871-879.1997

  396. 396.

    Wolff J, Cook GH, Goldhammer AR, Berkowitz SA. Calmodulin activates prokaryotic adenylate cyclase. P Natl Acad Sci USA. 1980;77:3841-3844.

    Not in our library10.1073/pnas.77.7.3841

  397. 397.

    Wolff N, Sapriel G, Bodenreider C, Chaffotte A, Delepelaire P. Antifolding activity of the SecB chaperone is essential for secretion of HasA, a quickly folding ABC pathway substrate. J Biol Chem. 2003;278:38247-38253.

    Not in our library10.1074/jbc.m302322200

  398. 398.

    Woods RG, Burger M, Beven CA, Beacham IR. The aprX-lipA operon of Pseudomonas fluorescens B52: a molecular analysis of metalloprotease and lipase production. Microbiology. 2001;147:345-354.

    Not in our library10.1099/00221287-147-2-345

  399. 399.

    Wooldridge KG, Kizil M, Wells DB, Ala'aldeen DA. Unusual genetic organization of a functional type I protein secretion system in Neisseria meningitidis. Infect Immun. 2005;73:5554-5567.

    Not in our library10.1128/iai.73.9.5554-5567.2005

  400. 400.

    Worsham LM, Trent MS, Earls L, Jolly C, Ernst-Fonberg ML. Insights into the catalytic mechanism of HlyC, the internal protein acyltransferase that activates Escherichia coli hemolysin toxin. Biochemistry. 2001;40:13607-13616.

    Not in our library10.1021/bi011032h

  401. 401.

    Worsham LM, Langston KG, Ernst-Fonberg ML. Thermodynamics of a protein acylation: activation of Escherichia coli hemolysin toxin. Biochemistry. 2005;44:1329-1337.

    Not in our library10.1021/bi048479l

  402. 402.

    Young J, Holland IB. ABC transporters: bacterial exporters-revisited five years on. Biochim Biophys Acta. 1999;1461:177-200.

    Not in our library10.1016/s0005-2736(99)00158-3

  403. 403.

    Zaretzky FR, Gray MC, Hewlett EL. Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous haemagglutinin interaction. Mol Microbiol. 2002;45:1589-1598.

    Not in our library10.1046/j.1365-2958.2002.03107.x

  404. 404.

    Zecchinon L, Fett T, Desmecht D. How Mannheimia haemolytica defeats host defence through a kiss of death mechanism. Vet Res. 2005;36:133-156.

    Not in our library10.1051/vetres:2004065

  405. 405.

    Zhang Y, Bak DD, Heid H, Geider K. Molecular characterization of a protease secreted by Erwinia amylovora. J Mol Biol. 1999;289:1239-1251.

    Not in our library10.1006/jmbi.1999.2846

Cited by papers we hold 9

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.